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With increasing longevity the population of the world is becoming older and there are 
growing numbers of people over the age of 65 years. This has implications for 
services providing psychological treatment to older people as there is likely to be an 
increasing demand for evidenced-based treatments such as Cognitive Behaviour 
Therapy (CBT) in the coming years. There are, however, relatively few clinical 
psychologists specialising in working with older people and therefore additional ways 
of dealing with the growing demands are essential. Computerised Cognitive 
Behaviour Therapy (CCBT) offers one potential option and NICE recommends 
Beating the Blues (BTB) as the most clinically and cost-effective package for treating 
depression. However, no study to date has explored the use of BTB with older people.  
 
Objective 
The objective of the study was to address this gap in the literature and had the 
following aims: 1) to explore the uptake rate of BTB with older people; 2) to explore 
the characteristics of older people opting to receive BTB; 3) to explore the drop-out 
rate from BTB with older people; and 4) to determine if BTB was effective in reducing 
symptoms of depression and anxiety in older people experiencing these difficulties. 
The findings were compared to previous research on BTB with younger adults. 
 
Methodology 
A between-groups, repeated measures design (with assessment time as the repeated 
measure) was used. Participants were given a free choice of receiving BTB plus 




usual was provided by clinicians from older people community mental health teams 
(e.g. psychiatric nurses) and the only constraint that was placed in this was that no 
face-to-face psychological therapy from an accredited therapist could be provided. 
The participants opting to receive BTB also completed eight sessions of BTB on a 
weekly basis.  All participants completed a range of outcome measures prior to 
commencing treatment (pre), after eight weeks (post) and after a further 4 weeks (one 
month follow-up).  
 
Results & Discussion 
The results indicated that 56.9 per cent of the participants opted to receive BTB and 
they reported having significantly more experience and confidence using a computer 
than those who declined BTB.  It was also found that 72.7 per cent of older people 
completed all eight sessions of BTB (27.3 per cent discontinuation rate). This was 
comparable to what has been found in previous studies of BTB with younger adults. A 
two (treatment group) x three (time) repeated measures ANOVA revealed that, in 
comparison to the TAU group, the BTB+TAU group showed statistically significant 
greater improvements  on measures of depression and anxiety by the end of treatment. 
This was maintained at one month follow-up. Furthermore, in comparison to the TAU 
group the BTB had a higher percentage of participants who met criteria for clinically 
significant improvement by the end of treatment and at one-month follow-up. The 
results suggest that BTB is an acceptable and effective treatment for older people 







CHAPTER 1 – INTRODUCTION 
1.1 CONTEXT 
1.1.1 Changing Demographics of the Population 
Much coverage has been given to the fact that life expectancies have greatly increased 
over the last six decades (United Nations, 2010). As illustrated in Table 1.1, the 
increase in longevity since the 1950’s has been a global trend that is predicted to show 
a similar pattern over the next 60 years and beyond (United Nations, 2010).  
 
Table1.1 Life expectancy (in years) by year, gender and region 
 YEAR 
 1950-1955  2005-2010  2060-2065  2095-2100 
 Male Female  Male Female  Male Female  Male Female 
REGION            
United Kingdom 66.7 71.8  77.4 81.7  83.8 88.1  87.3 91.6 
North America 65.8 71.7  75.6 80.7  82.4 87.4  85.9 91.0 
Europe 62.0 68.0  71.4 79.3  80.8 86.4  84.7 90.1 
Oceania 58.2 63.1  74.3 79.0  81.7 86.0  84.6 88.9 
South America 50.2 53.8  69.5 76.5  78.3 84.1  81.6 87.2 
Asia 42.8 43.1  67.2 70.9  76.3 80.6  79.8 83.9 
Africa 36.9 39.5  54.0 56.3  69.3 73.7  75.0 79.2 
World 46.7 48.7  65.7 70.1  75.2 79.9  79.0 83.3 
Source: United Nations (2010) 
 
One of the impacts of increased longevity has been that the world’s population has 
become increasingly older over the last 60 years, with a large rise in the proportion of 
people who are over the age of 65 years. Table 1.2 summarises the percentage of the 
population that are over the age of 65 years by different regions of the world and 
highlights the world wide population of older people
1
 is expected to show an increase 
over the next 60 years from just over 525 million to just under 2 billion by 2070 
(United Nations, 2010).  
 
                                                 
1
 An older person in the remainder of this study refers to an individual(s) over the age of 65 years 




Table 1.2 Projected percentage of the population over 65 years by year and region 
 YEAR 
 1950  2010  2070  2100 
REGION        
United Kingdom 10.8  16.6  25.8  27.7 
North America 8.2  13.2  22.9  26.0 
Europe 8.2  16.2  26.5  27.0 
Oceania 7.4  10.7  20.9  24.9 
South America 3.5  7.1  25.9  28.8 
Asia 4.1  6.7  22.9  25.9 
Africa 3.3  3.5  9.6  15 
World 5.2  7.6  19.5  22.3 
More Developed 7.9  15.9  25.7  27.0 
Less Developed  3.9  5.8  18.5  21.6 
Least Developed  3.3  3.4  10.6  15.7 




Table 1.2 also highlights that the growth in the ageing population is most apparent in 
developed parts of the world (although it is also occurring in less developed regions). 
More developed regions often have low fertility rates combined with the greatest life 
expectancies and it is this combination that gives rise to the most rapidly aging 
populations (United Nations, 2010). At present the UK has the 11
th
 fastest growing 
aging population in the world, and apart from Japan, the next 20 fastest growing aging 
populations are within Europe, whilst the USA is placed at 32 (United Nations, 2010).  
With the first of the ‘baby boomer’ cohort
2
 now reaching the age of 65 years this is 
likely to further increase the percentage of the population of older people in the 
coming years.  
 
It is also evident that the largest and most rapid increases in the age demographics are 
within the ‘oldest old’ sections of society (i.e. people over the age of 80 years) where 
a five fold increase is expected by the year 2070 (United Nations, 2010). Furthermore, 
                                                 
2
 ‘Baby boomers’ is the term  often used for individuals born in the years shortly following the 2
nd
 




the number of people aged 100 years and over is predicted to show approximately an 
eighteen fold increase by 2070 (United Nations, 2010).  
 
Laidlaw and Pachana (2009) highlight the importance of the changing age 
demographics of the population in relation to clinicians who provide treatment to 
older people who are experiencing psychological problems, such as depression and 
anxiety.  Consistent with Laidlaw and Baikie (2007) and Knight et al (2009), Laidlaw 
and Pachana (2009) note that with increasing numbers of older people who are living 
longer, and with the first ‘baby boomers’ turning 65 in 2011, this may translate into a 
large increase in the number of older people with depression and anxiety in the 
coming years. Knight et al (2009) also suggests that newer cohorts of older people 
may be more receptive to receiving input from mental health services than previous 
cohorts of older people.  All these factors may therefore lead to an increase in the 
demand for treatments for these disorders amongst older people.  
 
1.1.2 Prevalence Rates of Anxiety and Depression in Older People 
Depression has consistently been found to be one of the most common psychological 
difficulties older people can experience (Blazer, 1994; Blazer, 2002; Djernes, 2006; 
Steffens et al, 2009; Blazer, 2010a) and it frequently occurs with co-morbid 
symptoms of anxiety (Shaub & Lindeen, 2000, Kvaal et al, 2008; Van der Weele, 
2008, Kessler et al, 2010), so much so that it has been argued that whenever 
symptoms of anxiety are present in an older person, an assessment for depression 





The Household Psychiatric Morbidity Surveys (Singelton et al, 2001; McManus et al 
2009) were commissioned by the Department of Health, the Scottish Executive and 
the National Assembly for Wales to obtain detailed information about the prevalence 
of different psychiatric disorders found in individuals living in households in Great 
Britain. The surveys, which utilised the Clinical Interview Schedule – Revised (CIS-
R) to obtain an ICD-10 diagnosis, found that the combination of both depression and 
anxiety in older people (and younger adults) has consistently been identified as the 
most prevalent category of psychological disorders. (Singelton et al, 2001; McManus 
et al, 2009). The results of these two surveys are summarised in Table 1.3.  
 
Table 1.3 Prevalence of psychological disorders by age category  
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As can also be seen from Table 1.3, the Psychiatric Morbidity Surveys indicate that, 
in comparison to younger adults, older people show lower prevalence rates for all the 
psychological disorders highlighted. Similar prevalence rates for these psychological 
disorders in older people, and similar findings of lower prevalence rates of DSM-IV 
defined major depressive episode in older people compared to younger adults, has 





A limitation of the studies by Singelton et al (2001), McManus et al (2009) and 
Kessler et al (2010) is that they do not include any older people living in nursing 
homes, where significantly higher prevalence rates of depression have been found 
(Jongenelis et al, 2004). A review of the literature by Jongenelis et al (2003), for 
example, found prevalence rates of 6-26 per cent for major depression, 11-50 per cent 
for minor depression and 30-48 per cent for sub-clinical depressive symptoms found 
in older people residing in nursing homes. In a more recent study, Gaboda et al (2011) 
found that 51.8 per cent of residents across 5445 nursing homes in the USA were 
diagnosed with depression. Such findings would suggest that the prevalence rates of 
anxiety and depression found in the household surveys by Singelton et al (2001), 
McManus et al (2009) and Kessler (2010) may be underestimates of the overall 
prevalence of these disorders amongst all older people.  
 
A review of the epidemiology of depression in older people living in the community, 
including studies from Europe, Australia, North America and Asia (Beekman et al 
1999), has suggested that an important factor that must be considered when exploring 
the prevalence rates of depression in older people is the different methodologies used 
to assess depression across different studies. For example, some studies included in 
the review by Beekman et al (1999) used the DSM diagnostic criteria to identify cases 
of depression (Pahkala et al, 1995) whilst others use clinical cut-offs on assessment 
scales for depression (Lauritzen et al, 1996). The different methodologies used in 
different studies often results in variations in the ‘levels of caseness’ of depression 
explored in different studies (i.e. some examined clinically diagnosed major 
depressive disorder, whilst others examined sub-threshold symptoms of depression). 




found across the 34 studies included in the review by Beekman et al (1999) (ranging 
from 0.4 per cent to 35 per cent). However, Beekman et al (1999) argued that this 
variation diminishes when studies are grouped together by ‘caseness’ and they 
conclude that whilst clinically diagnosed major depressive disorder may be relatively 
rare in older people (1.8 per cent), when all depressive syndromes deemed to be 
clinically relevant are taken together it yields a prevalence rate of 13.5 per cent.   
 
A weakness of the review by Beekman et al (1999) is that it included studies with an 
age inclusion criteria below the age of 65 years (as low as 55 years) and excluded 
studies exploring “the oldest age groups” (p 307). It did not, however, report what the 
criteria for defining the oldest age groups were. In addition, in line with the discussion 
above, the authors, conclude that as the studies included in their review did not 
include the oldest age groups or individuals living in nursing homes the “true 
prevalence of depression in the elderly is likely to be somewhat higher” (p 307).  
 
A more recent study by McDougall et al (2007) explored the prevalence of different 
levels of caseness of depression in older people throughout England and Wales, 
ranging from sub-clinical depression to case-level depression. The study used the 
GMS-AGECAT system, which, depending on the responses of the individuals, 
generates a diagnosis of depression at differing levels of increasing severity, with 
level zero indicating no or very few symptoms of depression, level one and two 
indicating sub-clinical depression of different severity and level three and four 
indicating case level depression of different severity (a further psychotic subtype can 
also be obtained).  The results of an initial analysis, which excluded individuals with 




8.7 per cent, whilst a lower prevalence of 2.7 per cent was found for severe case-
levels of depression.  It was also apparent in this study that there were significant 
differences in the prevalence rates of depression found in the different regions that 
were sampled. For example, a prevalence rate of 3.5 per cent was found in 
Cambridgeshire, whilst a rate of 14.8 per cent was found in Newcastle.  
 
This variation in the prevalence of depression found in older people across different 
regions of the UK would indicate that, in addition to the methodological differences 
between studies, the variation may also be accounted for by population differences 
across regions. Indeed, the study by McDougall et al (2007) found an association 
between higher prevalence rates of depression and higher social deprivation, greater 
functional disability and more medical co-morbidity, which have all been factors 
associated with depression in older people in a number of other studies (Cole & 
Dendukuri 2000; Blazer & Hybels, 2005). Even greater variation in the prevalence 
rates of depression may also be found when exploring rates in different countries. In 
line with this, a recent study across the USA (Steffens et al, 2009), found a total 
prevalence rate of 10.94 per cent (including older people with minor depression, 
major depression and those who were receiving medication for treating depression). 
This finding is slightly higher than what was found in the UK (McDougall et al, 2007) 
and in the Psychiatric Morbidity Surveys (Singelton et al 2000; McMannus et al 
2009), but slightly lower than the overall prevalence rates found in an earlier review 
including studies from many regions of the world (Beekman et al 1999) 
 
The variation in results found in studies exploring the prevalence of depression in 




different diagnostic methods used between studies, such as clinically diagnosed major 
depressive disorder or clinical cut-off scores on screening measures for depression), 
different samples of patients examined (i.e. community, nursing home, outpatients) 
and different areas of the world (where factors such as levels of deprivation may vary) 
(Djernes, 2006). Despite this variation in prevalence rates found between studies, 
Djernes (2006) suggests that whilst symptoms of depression, (which are clinically 
relevant and which could benefit from treatment), are arguably less prevalent in older 
people compared to younger adults, it is still a common problem affecting a 
significant number of older people. 
 
An important point to make at this stage is that whilst depression may affect a number 
of older people it is by no means an inevitable consequence of old age and the vast 
majority of older people do not experience depression. Indeed, a recent study by 
Carstensen et al (2011) suggests that emotional well-being improves from early 
adulthood into old age, which they state “flies in the face of stereotypes of 
ageing…where old age is viewed as a time of loss and sadness by younger people” 
(p21). Woods (2008) also discusses this issue, which he states has been referred to as 
the “well-being paradox” (p44), whereby despite the challenges that old age can bring 
(such as multiple losses, relative poverty, reduced independence, and increased 
physical health problems), older people often maintain greater life satisfaction and 
well-being than younger age cohorts. In light of these findings, different mechanisms 
and models have been proposed to account for the fact that older people may be more 
able than younger age cohorts to deal with the psychological stressors they often face 





Despite the findings of Carstensen et al (2011), it is important to acknowledge that the 
individuals who are experiencing psychological distress still account for a significant 
number of older people. Based on the evidence outlined above an estimate would be 
that at approximately 5-10 per cent of older people experience symptoms of 
depression and anxiety to the extent that they are likely to have a detrimental impact 
upon their wellbeing. Assuming that these prevalence rates do not decrease over the 
coming years in parallel with the projections for the increasing numbers of older 
people, this is likely to produce an overall increase in the numbers of older people 
experiencing these disorders.  
 
1.1.3 Impact of Depression and Anxiety in Older People 
1.1.3.1 Quality of Life, Mortality and Suicide 
It is clear, based on the diagnostic criteria for depression and anxiety, that both these 
disorders are subjectively unpleasant experiences, which can have a detrimental effect 
upon older people’s functioning and quality of life (Doraiswamy et al, 2001; 
Wetherell et al, 2004; Van der Weele, 2008).  Unutzer et al (2000), for example, 
found that depression was the third leading cause of reduced quality of life in older 
people, with only arthritis and heart disease having a greater association with reduced 
quality of life. Similarly, Bourland et al (2000) found that, in comparison to control 
participants without anxiety, older people diagnosed with generalised anxiety disorder 
reported significant reductions in their quality of life.  
 
In addition to the unpleasant nature of depression and anxiety, and the impact these 
disorder can have on quality of life, there is also evidence to suggest they are also 




(2009), in a prospective study of 3746 older people who were assessed as not having 
dementia at baseline, found that both moderate and severe depression was associated 
with increased mortality after 10 years. Furthermore, they found a ‘dose response 
relationship’ whereby increased severity and duration of depression at baseline was 
associated with greater mortality risk, with chronic depression increasing mortality by 
41 per cent (Shoevers et al, 2009). The authors argue that their findings were 
independent of other factors which they included in their analysis, such as a range of 
sociodemographic variables, levels of physical ill health and declines in intellectual 
functioning characteristic of the onset of dementia. Similar findings were reported in a 
study by Van der Weele et al (2008), which examined a sample of individuals over 
the age of 90 years. The results indicated that the presence of depression and 
depression co-morbid with anxiety at baseline increased the risk of mortality by 20 
per cent after an average of 3.3 years.  
 
The results of Shoevers et al (2009) and Van der Weele (2008) should, however, be 
treated with a degree of caution as, because of the correlational nature of the studies, 
it was not possible to infer any causal mechanisms that may account for the results. 
Nevertheless, these studies, along with a number of others which have documented 
similar findings of increased mortality in older people with depression and anxiety 
(Pennix et al, 2001; Schulz et al, 2002; Ryan et al 2008; Peters et al, 2010; Hamer et 
al 2011), highlight a further negative aspect of these disorders for older people.   
 
A possible factor that may in part account for the increase in mortality found in older 
people who have depression relates to suicide.  It is often reported older people have 




particularly older males, are at greater risk of committing suicide than any other age 
group (O’Connell et al, 2004; Duberstein & Heisel, 2008; Conwell, 2009; Erlangsen 
et al, 2011). Duberstein and Heisel (2008), for example, cite evidence that whilst the 
ratio of non-lethal suicide attempts to completed suicide is 20:1 in younger adults, the 
figure rises to 4:1 in older people.  In line with these findings, the most recent Centres 
for Disease Control and Prevention figures from the USA (CDC, 2007) indicate that 
whilst women show a peak in rates of suicide in their 40’s and then lower rates from 
their 60’s onwards, rates of completed suicide in males increase with age, with the 
highest rates found in males aged 75 years and above. This is summarised in Table 
1.4: 
 
Table 1.4 Rates of suicide (per 100 000) by age and gender 
Age Category (Years) Males Females 
15 – 19  11.03 2.48 
20 – 24  20.64 3.89 
25 – 29  20.43 4.69  
30 – 34  21.31 5.39 
35 – 39  22.34 6.35 
40 – 44  25.62 8.28 
45 – 49  27.01 8.75 
50 – 54  27.09 8.84 
55 – 59  25.04 8.00 
60 – 64  23.34 6.54 
65 – 69  22.43 4.48 
70 – 74  22.54 3.88 
75 – 79  32.49 4.01 
80 – 84  35.29 3.51 
85 + 45.35 3.20  
Overall rate for all ages  11.47 
Source: Centres for Disease Control and Prevention (2007) 
 
As can be seen from Table 1.4, there is over a three fold increase from the national 
average in suicide rates in males over the age of 75 years.  Despite these findings, a 
different pattern has emerged in the UK whereby it has been reported that older 




prevalence found within the age cohort of 25-34 years (Shah and Coupe, 2009). In 
addition, a review by Shah (2007), which explored rates of suicide across 62 
countries, found that only 25 countries had higher rates of suicide in older males 
compared to younger males, and 27 countries had higher rates in older females 
compared to younger females.  
 
Despite the variation between countries in the rates of suicide amongst older people, 
and differences in the trends in the rates found across different age groups, it is clear 
that with the overall numbers of older people projected to increase in the coming 
years this may translate into an increase in the number of suicides within this age 
group (Conwell, 2009). This increase is important in relation to depression as it is 
widely reported that there is a high prevalence of this disorder in older people who 
commit suicide (Conwell et al, 2002; O’Connell et al, 2004; Hawton & van 
Heerengen, 2009, Wiktorsson et al 2010). Wiktorsson et al (2010) argue that if efforts 
are not made to improve the provision of treatments for older people experiencing 
depression then the increasing numbers of older people in the population could lead to 
a large overall rise in the number of suicides   Given the HEAT target set by the 
Scottish Executive Health Department to reducing suicide rates in Scotland by 20 per 
cent by the year 2013 (SEHD, 2006), the importance of  providing effective 
treatments for older people experiencing depression is clear. Indeed, O’Connell et al 
(2004) argue that if psychiatric illnesses were ‘eliminated’ (i.e. completely treated and 
the person no longer experiences any symptoms), then 74 per cent of suicides in older 






1.1.3.2 Physical Health  
In terms of physical health, older people are at greater risk of experiencing certain 
acute illnesses such as stroke (Feigin et al, 2002). It is evident, however, that with the 
increase in life expectancy, older people are increasingly likely to have developed at 
least one chronic physical health condition, such as arthritis, hypertension, heart 
disease, etc. For example, The General Lifestyle Survey (ONS, 2009) highlighted 58 
per cent of people aged 65-74 years and 66 per cent of people aged 75 years and 
above reported suffering from at least one longstanding physical illness. These were 
significantly higher rates than found in younger age cohorts. Furthermore, this survey 
found that, in comparison to younger age cohorts, older people were more likely to 
have consulted their GP within the previous two weeks, had a higher average number 
of GP consultations within the previous year, were more likely to have attended a 
hospital outpatient appointment and were more likely to have been admitted as an 
inpatient to a general hospital. 
 
The high prevalence of physical health conditions in older people is particularly 
important when considered together with anxiety and depression, as there is evidence 
to suggest that these disorders can lead to an exacerbation in the pain, distress and 
disability associated with physical health problems, as well as having a negative 
impact in terms of treatment outcomes for such problems (Mousavvii et al, 2007). For 
example, a number of studies have consistently shown that individuals diagnosed with 
depression following a stroke exhibited slower recovery times, increased functional 
impairment, reduced quality of life and increased mortality, when compared to those 
who were not diagnosed with depression (Parikh et al, 1990; Ramasubbu et al, 1998; 




Similarly, a systematic review of the literature by Lichtman et al (2008) suggested 
that there has been a consistent finding of a reciprocal relationship between 
depression and coronary heart disease (CHD). They highlighted that not only is there 
a much higher prevalence rate of depression in individuals with CHD, but that the 
presence of depression increases mortality rates and reduces factors such as adherence 
to medications and cardiac rehabilitation programmes, which can have an adverse 
affect on the persons functioning.  
 
In addition, Lin et al (2003) highlight that one third of people over the age of 65 years 
have a diagnosis of osteoarthritis and individuals who also have co-morbid depression 
often report significantly more pain and functional impairment as a result of their 
arthritis, compared to those without depression. Similar findings were reported in a 
more recent study by Kojima et al (2009), which found severity of depression, as 
assessed by the Beck Depression Inventory, was positively correlated with the 
perceived levels of pain reported by individuals with rheumatoid arthritis. Similarly, 
Morris et al (2011), in an 18 year follow-up study, found that depression was 
associated with increases in functional disability and self-reported poor physical 
health in individuals with rheumatoid arthritis.  
 
A number of studies have also shown a range of negative consequences of late life 
anxiety disorders upon physical wellbeing including: increased physical disability, 
reduction in activities, decreased sense of wellbeing and ove- use of medical services 
(Roberts et al, 2001; Lenze et al, 2001; Wetherell et al 2004; Brenes et al, 2005). 
Falling is a common problem amongst older people and can lead to extensive physical 




2006). There is evidence to suggest that anxiety is a risk factor that can increase an 
older person’s likelihood of falling and that one of the sequelae of this is a loss of 
independence as a result of increased anxiety levels (Chang et al, 2004).  
 
The studies mentioned above highlight that the presence of depression and anxiety 
may have a significant adverse effect on the physical health and wellbeing of an older 
person as well as significantly reducing their quality of life. The fact that depression 
and anxiety can interact with factors such as adherence to treatment and the duration 
of hospital admission times also has financial and resource implications (Hosaka et al, 
1999). Indeed, Katon (2003) highlight the large increase in medical costs associated 
with under-treated depression in older people.   
 
1.1.4 Conclusion  
It is widely recognised that there can be a number of challenges in aging (Laidlaw & 
McAlpine, 2008; Laidlaw & Pachana, 2009).  Older people can be at greater risk of 
reduced physical health functioning, reduced independence and multiple losses and 
bereavements. These are all factors which may increase the risk of an older person 
becoming depressed and anxious. Indeed, due to the challenges which older people 
can face, in the past some have falsely assumed that depression and anxiety are 
‘normal reactions’ to becoming old (Blanchard, 1996; Unutzer et al, 1999; 
Neiremberg, 2001).  This is clearly not the case, as anxiety and depression are not 
inevitable consequences of the ageing process (Laidlaw & Pachana, 2009). Carstensen 
(2011), for example, highlighted that improved emotional well-being is associated 
with greater age and models have been proposed to help understand how many older 




2008). However, it is also clearly the case that a significant proportion of older people 
develop depression and anxiety that is clinically significant and which would benefit 
from treatment.  
 
With the evidence demonstrating a demographic shift towards an ageing population 
across the world it could be argued that it is essential that there is an increased focus 
on the treatment of psychological problems, such as anxiety and depression, for older 
people. At a basic level, assuming the prevalence rates of anxiety and depression 
remain stable, the increase in the population of older people would suggest that there 
is going to be a corresponding increase in the number of older people with depression 
and anxiety and, in turn, an increase in the demand for treatments of such difficulties 
amongst this population.  
 
In addition, it is evident that the largest increases in the population are amongst the 
‘oldest old’ (i.e. those above 85 years: United Nations, 2010). There is evidence to 
suggest that increasing age increases the chances of developing chronic physical 
health problems, which given the aging demographic would suggest there is likely to 
be an increase in the numbers of people within this age cohort living for longer with 
physical health problems (ONS, 2009). It has also been recognised that the prevalence 
of depression is increased in people with chronic medical problems. Given the 
evidence to suggest that depression and anxiety reduces an individual’s ability to cope 
with physical health problems, increases their use of health care services and 
increases their morbidity and mortality, this group of people will potentially be most 





1.2.  TREATMENT FOR DEPRESSION AND ANXIETY IN OLDER PEOPLE 
1.2.1 Introduction to Treatments 
Based on the information outlined in the previous sections, the development of 
effective treatments for depression and anxiety in older people is essential. Although 
in comparison to adults of working age the overall number of treatment outcome 
studies is relatively small with older people (Cuijpers et al, 2009), it has been 
consistently demonstrated that both psychological and pharmacological treatments for 
depression and anxiety are effective with both age groups (Stanley et al, 1996; Gerson 
et al, 1999; Wilson et al 2001; Kapczinski et al 2003; Ayers et al, 2007; Hunot et al, 
2007; Wilson et al, 2008; Stanley et al, 2009; Serfaty et al, 2009). Studies which have 
directly compared psychological and pharmacological treatments suggest that they 
both produce equal benefits in the short-term, whilst psychological treatments such as 
Cognitive Behaviour Therapy (CBT) often produce greater benefits at longer-term 
follow-up (DeRubesis et al, 1999; Bortollotti et al, 2008). This has been a consistent 
finding in both adults of working age and older people (Pinquart et al, 2006; Laidlaw 
et al, 2008), highlighting the importance of psychological treatments in both these 
populations.  
 
It has also been suggested that the effect sizes produced in meta-analyses of 
psychological treatments for depression in older people are broadly equivalent to 
those found in meta-analysis with adults of working age (Scogin & McElreath, 1994; 
Cuijpers et al 1998; Pinquart et al, 2006), which would suggest such treatments 
produce equal benefits in both age groups. The most recent meta-analysis exploring 
psychological treatments for depression in older people by Cuijpers et al (2009) 




examined 112 studies of which 20 were with older people and 92 were with adults of 
working age. The results indicated that there was no significant difference in the 
effect size produced by studies with older people (d = .74) compared to those with 
younger adults (d =. 67), with both age cohorts showing moderate to large effect sizes 
in favour of psychological treatments over control conditions. These findings of large 
effect sizes and no significant differences between the two age cohorts were 
maintained when the authors excluded certain studies from the analysis; including 
removing outlier studies (i.e. studies with effect sizes greater that 2.0); excluding 
studies of specific populations that would limit if all older people or all younger adults 
could participate (i.e. student cohorts, women with postpartum depression and 
depression as a result of a specific medical condition); and when an individual study 
yielded several effect sizes only the smallest one was included.  
 
Despite these findings, a limitation of the results was that the authors only included 
pre-post treatment comparisons and no results regarding follow-up were analysed, 
which means no conclusions can be drawn regarding the differential effect of 
psychological treatments between younger and older people at longer term follow-up. 
Cuijpers et al (2009) also highlight there were a number of differences between the 
studies with older people compared to those with younger adults. For example, whilst 
CBT was the most common psychological intervention used in both age groups (42.3 
per cent in older people and 48.6 per cent in younger adults), in comparison to 
younger adults, few studies with older people examined interpersonal psychotherapy 
(three older people studies versus nine younger adults studies), problem-solving 
therapy (three older people studies versus eleven younger adults studies), supportive 




behavioural activation treatments (one older people studies compared to nine younger 
adults studies). In contrast a number of outcome trials with older people examined life 
review therapies (five studies), which was not examined in any with younger adults. 
When the authors only included studies examining CBT in their analysis the results 
again indicated that studies with younger adults and studies with older people had 
moderate effect sizes in favour of CBT over control conditions (d = .68 and d = .65 
respectively), with no significant differences between the two groups.  
 
Cuijpers et al (2009) also highlight some limitations in the evidence-base for 
psychological treatments for depression in older people that emerged from their meta-
analysis. For example, they suggest that only one study (3.8 per cent of the total older 
people studies) with older people compared to 31 studies with younger adults (21.5 
per cent of the total younger adult’s studies) recruited participants from a clinical 
sample. This finding could potentially over-inflate the effect sizes found in studies 
with older people, if it is assumed that (in comparison to participants from a clinical 
sample) those recruited from a non-clinical sample may respond more favourably to 
treatment. Some evidence for this assumption was indeed found by Cuijpers et al 
(2009), whereby studies recruiting participants from clinical samples had lower effect 
sizes than other studies with participants who were not recruited from a clinical 
sample (Cuijpers et al, 2009). A related limitation was that although studies with 
severe depression in younger adults were not as common as those with mild-moderate 
depression, no studies explored severe depression in older people.  A further 
limitation of the results found in the meta-analysis was that the mean age of older 




cannot be drawn regarding the effectiveness of psychological treatments for 
depression in ‘older-old’ age cohorts. 
 
Despite the limitations of the meta-analysis by Cuijpers et al (2009), the authors 
conclude that, whilst more research is required exploring psychological treatments 
with older people, (particularly with ‘older old’ participants and with individuals 
recruited from a clinical sample), at present the evidence suggests that psychological 
treatments (and in particular CBT) are equally effective in older people as well as 
younger adults (Cuijpers et al, 2009). 
 
Table 1.6 provides a brief summary of the main conclusions of other meta-analyses 
that have examined psychological treatments for depression with older people over 
the years. A theme that has emerged from these studies has been that CBT appears to 
be the form of psychological treatment that has been the most systematically 
evaluated in the published literature. A consistent limitation of each of these meta-
analyses has been that, the relatively small number of studies exploring alternative 
psychological treatments with older people, compared to younger adults, makes it 
difficult to draw any firm conclusions about CBTs relative efficacy, when compared 
to other psychological treatments with older people (Koder et al, 1996; Wilson et al, 
2008).  
 
The finding of CBT being the most empirically evaluated psychological treatment for 
depression in older people is borne out in a recent meta-analysis by Wilson et al 
(2008), which evaluated the evidence from randomised control trials of psychological 




Table 1.5 Summary of meta-analyses examining psychological treatments for 
depression with older people.  
Study Main Conclusions 
Scogin et al (1994) 
 
Psychological treatments for depression in older people are effective in comparison to no 
treatment or placebo control conditions. The effect sizes produced are comparable to those 
found in studies with younger age groups. A limitation is that too few older people studies 
exist to allow a comparison between the relative efficacies of different types of treatment 
for depression with this age group. 
 
Koder et al (1996) 
 
CBT is an effective treatment for depression in older people in comparison to no treatment 
or placebo conditions. A limitation is that there are not enough studies of sufficient quality 
to allow a comparison of CBTs efficacy relative to other psychological treatments for 
depression in older people.  
 
Engels et al (1997) 
 
Psychological treatments are effective for treating depression in older people and Cognitive 
and Behavioural treatments appear to be the most effective psychological treatments. 
Individual therapy appears to be more effective than group therapy for treating depression 
in older people 
 
McCusker et al (1998) 
 
Pharmacological and psychological treatments (such as cognitive and behavioural 
therapies) are moderately effective in treating depression in older people, compared to no 
treatment/placebo controls. A limitation was that only a small number of studies, in some 




The effect sizes of psychological interventions for treating depression in older people are 
large in community samples and are comparable to those found in younger populations. A 
limitation was that participants in the identified studies often were not recruited from 
clinical samples and the authors suggest more research is required with these populations. 
 
Gerson et al (1999) 
 
A significantly greater amount of research has focused on pharmacological treatments for 
depression in older people than on psychological treatments. Both, however, are effective in 
treating depression in older people. Too little data is available to allow a direct comparison 
between the relative efficacies of different treatments for depression in older people.  
 
Pinquart et al (2001) 
 
Psychological treatments are more effective in comparison to control conditions in treating 
depression in older people. CBT, Psychodynamic and Supportive Therapies appear to be 




Psychological and pharmacological treatments are both efficacious in treating depression in 
older people, with some evidence that psychological treatments are more effective with 
patients with milder levels of depression. Very few studies have directly compared 
psychological and pharmacological treatments to control conditions in older people to draw 




“There is no doubt psychological treatments are effective in treating depression in older 
people” (p 1146) and the obtained effect sizes are comparable to those found in meta-
analyses with younger adults.  
 
Wilson et al (2008) 
 
There is a paucity of RCTs exploring psychological treatments, of adequate quality and 
sample size with older people experiencing depression. CBT appears to be effective in 
comparison to waiting list controls but too little data exists to draw conclusions about its 
efficacy relative to other treatments.  
 
Cuijpers et al (2009) 
 
Psychological treatments for depression are equally effective for older people as it is for 
younger adults. There is, however, relatively little research with older people than with 
younger adults, particularly with severe levels of depression and from clinical samples.  
 
 
In this study, the authors classified different treatments into Cognitive Behavioural 




Supportive/Counselling Therapies.  The aim of the analysis was to firstly examine the 
effectiveness of the different psychological treatments to waiting list or standard care 
control groups. The second aim was to explore the relative effectiveness of different 
types of psychological treatments. In conducting their analysis the authors pooled the 
results from studies utilising the same outcome measures using weighted mean 
differences. When different outcome measures were employed between studies the 
authors pooled the results using the standardised mean difference. 
 
Of the 82 studies identified only 12 met the inclusion criteria and of these only nine 
were available for inclusion in the meta-analysis as the authors reported being “unable 
to obtain suitable usable data” (p5) for three studies. Furthermore, the results 
indicated that, in terms of psychological treatments, only studies utilising CBT and 
psychodynamic therapy, as the primary treatment, could be identified, although three 
‘active comparator’ control treatments including; reminiscence, visual imagery and 
education were also included .  
 
In terms of the main analysis, only five studies, all of which used CBT, compared this 
psychological treatment to waiting list/no active treatment control conditions. No 
other studies were identified that compared other forms of psychological treatment to 
waiting list controls. The results of these five studies, all of which used the HRDS to 
assess treatment outcome, showed that CBT was significantly better than waiting list 
controls at reducing symptoms of depression. It was, however, identified by Wilson et 
al (2008) that only one of these studies examined clinical response (i.e. how many 




were found between the CBT and a placebo drug group that was used as a non-active 
control condition in this study. 
 
It was also identified that three trials compared CBT to psychodynamic therapy and 
no significant difference was found between these two treatment modalities in terms 
of reductions in psychopathology or clinical response to treatment. Similarly, in a sub-
group analysis of three CBT studies that compared CBT to active control conditions 
(i.e. reminiscence, visual imagery and education), no significant differences were 
found between these treatment conditions in terms of reductions in psychopathology 
as assessed by the GDS, although a significant difference was found on the HDRS in 
favour of CBT.  
 
Based on the results of their meta-analysis, Wilson et al (2008) conclude that there is 
a relative lack of high quality research that has explored psychotherapeutic treatments, 
other than CBT, which they state is more effective than waiting list controls. An 
important point to make in this regard is that the types of treatment that were 
categorised as CBT within this study were heterogeneous and included, for example, 
bibliotherapy and problem-solving therapy. The authors also highlight the lack of 
research that has focused on outcomes such as quality of life following treatment.  
 
In terms of anxiety disorders, Ayers et al (2007) highlight that whilst the amount of 
research generally on psychological treatments is smaller with older people than 
adults of working age, studies focusing on the treatment of anxiety with older people 
lags even further behind. Ayers et al (2007) conducted a review which identified 17 
studies that have examined psychotherapeutic evidence based treatments (EBTs) for 




types of EBTs were found to be effective in treating anxiety disorders, namely: CBT, 
cognitive therapy
3
, relaxation training and supportive therapy.  The results also 
suggested that CBT was the most common therapeutic approach, being used in nine 
studies, whilst a further three studies used Cognitive Therapy. The authors conclude 
that all the treatments reviewed are effective in treating anxiety in older people, with 
CBT having the most significant evidence-base. Ayers et al (2007) also suggest that 
the results of the studies that were included in their review are not as strong as the 
results found in studies exploring the effectiveness of psychological treatments in 
younger adults. It is, however, unclear as to how they reached this conclusion as they 
did not employ any statistical analysis to examine the results from the studies 
included in their review, (for example, using meta-analytic techniques). Such an 
approach would allow a comparison with meta-analyses undertaken with younger 
adults.   
 
This latter issue is addressed in a more recent meta-analysis (Hendricks et al, 2008) 
which examined the effectiveness of CBT in treating anxiety disorders in older 
people. The results indicated that seven studies, with a total of nine comparison 
conditions, met the inclusion criteria (four comparisons between CBT and waiting list 
controls and five comparisons between CBT and active control conditions).  The 
pooled standardised mean difference (SMD), calculated by the authors, suggested that 
in comparison to both waiting list and active control conditions, CBT was more 
effective (SMD = -.44 and SMD = -.51 respectively). An interesting aspect of these 
results is that CBT appeared to be more effective when compared to an active control 
than when compared to a waiting list control. The authors report an expectation that 
                                                 
3
 The authors differentiated CBT from Cognitive Therapy, whereby CBT was defined as also 




as participants who were in an active control condition also received some form of 
treatment, the relative efficacy of CBT would not be as great in comparison to a 
waiting list control condition. However, Hendricks et al (2008) suggest that the 
opposite pattern that they found was likely the result of two studies, which compared 
CBT to an active control, having a very large effect in favour of CBT. The authors 
also suggest the relative small number of studies included in the analysis meant the 
results were more sensitive to the effects from single studies. Despite the limitations 
produced by the small number of available studies for analysis, on the basis of their 
results Hendricks et al (2008) conclude that CBT is an effective treatment for anxiety 
in older people. There were, however, some additional limitations of this study 
particularly as the majority of the included studies only involved patients with 
generalised anxiety disorder (GAD), meaning these findings may not be applicable to 
other anxiety disorders. Furthermore, data regarding longer term follow-up were not 
included in their meta-analysis, meaning that conclusions regarding the long-term 
benefits of CBT for treating anxiety in older people cannot be drawn from this study.  
 
Wolitzky-Taylor et al (2010) also highlight that the magnitude of the effect sizes 
obtained in the meta-analysis by Hendricks et al (2008) are smaller than what has 
been observed in published meta-analysis exploring CBT for anxiety in younger 
adults (e.g. Western et al, 2001).  Wolitzky-Taylor et al (2010) suggest that whilst 
CBT appears to be effective in treating anxiety, particularly GAD, in older people, 
these benefits may be improved by designing treatment protocols to make them more 






1.2.2  CBT Development and Use with Older People 
As alluded to in the previous section, CBT has been the most evaluated psychological 
treatment for depression and anxiety in older people. CBT was first developed by 
Beck (Beck, 1976). At its most basic level CBT developed from a cognitive model 
that proposed emotional disorders, such as depression and anxiety, arise from 
dysfunctional information processing, which in-turn has a maintenance effect on these 
disorders (Beck, 1976). CBT uses different cognitive and behavioural techniques to 
target and correct this dysfunctional information processing and change unhelpful 
behaviours, which in-turn is proposed to produce symptomatic reduction.  
 
More specifically, the premise of CBT is that through early developmental 
experiences an individual develops underlying beliefs and assumptions that guide 
their thinking, behaviour and the way they interpret themselves and events in their 
world (Beck, 1976). In the case of emotional disorders the person may hold 
dysfunctional beliefs and assumptions about themselves and the world, which can be 
activated through situational events and subsequently cause the individual to develop 
symptoms of emotional disorders. The result of this is the person thinks and behaves 
in a way that maintains their symptoms. An example may be a child who is harshly 
treated and criticised by their parents, with little explicit signs that they are loved, may 
grow up with an underlying belief that they are worthless and unlovable. They may 
manage this by developing the assumption that to be worthy and loved they should 
always make sure they please others so they are liked and can therefore avoid any 
criticism.  A subsequent event such as a divorce may then trigger a pattern of thinking 
and behaving such as believing this situation shows they are truly worthless and 




others also see them as worthless. They may subsequently interpret other events as 
reinforcing the belief that they are unlovable and worthless. This pattern of thinking 
and behaving subsequently maintains the emotional distress they experience. A more 
detailed description of the initial development of the model of CBT can be found in 
Beck (1976).  
 
CBT has now been widely investigated and applied to a range of emotional disorders 
with a vast body of evidence demonstrating its efficacy (Bisson, 2007; Hunot, et al 
2007; Wilson et al, 2008; Eccleston et al, 2009; Hay et al, 2009; NICE, 2010).  Over 
the years the way the initial model has been applied has developed and has varied in 
terms of how it is used with different problems and populations (e.g. Hawton et al, 
1989; Wells, 1997; Laidlaw et al, 2003). It could be argued that CBT does not form 
an individual specific treatment in itself but rather a range of different therapeutic 
techniques. A commonality amongst all the approaches of CBT is that it is present- 
focused, targeting the symptoms and difficulties the person is currently experiencing. 
It is also highly structured, with clear procedures for how the different skills and 
techniques of CBT are provided to patients to help them manage their symptoms. The 
emphasis of treatment is on helping the patient to identify their dysfunctional patterns 
of thinking and behaving. This is then changed through techniques that show the 
person that such thoughts are not fixed, but rather are hypotheses to be tested 
empirically and subsequently changed to more adaptive, helpful and realistic thoughts 
and behaviours.  
 
A detailed description of the treatments can be found in Beck et al (1979) for 




detailed description of how CBT can be used for treating depression and anxiety with 
older people. This is also described more recently in Laidlaw and Thompson (2008) 
and Laidlaw and McAlpine (2008). 
 
A randomised controlled trial by Laidlaw et al (2008) aimed to explore the efficacy of 
CBT, using a treatment manual that made specific modifications to CBT for use with 
older people, in line with what is outlined in Laidlaw et al (2003). This treatment 
manual is described fully in Thompson et al (2000). This study randomly allocated 40 
participants to either CBT or treatment as usual (TAU) delivered by a GP, which was 
described by the authors as “generally (comprising) pharmacotherapy” (p 843) as 
indicated by the fact that 80 per cent of participants in the TAU group were provided 
with antidepressants. It was, however, also apparent that 50 per cent of participants in 
the TAU group were also referred to a psychiatrist, community psychiatric nurse or 
district/practice nurse for treatment, which could suggest pharmacotherapy was not 
the sole treatment provided in the TAU condition. 
 
The results of this study indicated that both treatment groups achieved statistically 
significant improvements on a range of outcome measures relating to depression, 
functioning and quality of life by the end of treatment. These improvements were 
maintained by six month follow-up. An initial analysis did not reveal any statistically 
significant greater benefit for CBT over TAU, with the exception that when baseline 
characteristics were controlled for, hopelessness was significantly more reduced in the 





However, when the authors controlled for whether or not the participants were 
married, the results indicated that, in comparison to TAU, those in the CBT group had 
statistically greater improvements by the end of treatment and by six month follow-up 
on a range of outcome measures, whereby those who were living alone showed 
greater improvements than those living with a spouse. Laidlaw et al (2008) suggest 
that this finding may have been the result of those living alone having more time to 
complete homework tasks. Furthermore, the author’s cite evidence suggesting that 
some older people in long-term marriages often have an affectively neutral 
interactional style, which a depressed person may experience as isolating. They 
therefore suggest levels of intimacy within a marriage are an important consideration 
in terms of the support it will provide, rather than the actual existence of a marriage. 
Despite these suggestions, Laidlaw et al (2008) do not provide any evidence from 
their study that would lead to such conclusions (i.e. they did not report on homework 
completion rates or the levels of intimacy within the marriages of the participants). An 
alternative explanation for their findings could be that those who were living alone 
were more socially isolated and therefore benefited more from the non-specific 
aspects of CBT, such as the increased contact and interaction with other people. A 
control condition that provided attention and interaction, but no specific treatment, 
would be required to analyse this hypothesis further.  
 
A further methodological weakness of this study was that it was evident that there was 
a wide range in the number of CBT sessions that participants received (i.e. between 
two and 17, with a mean of eight sessions). Laidlaw et al (2008) do not, however, 
report how much this variation was a result of the planned discontinuation of CBT, or 




number of treatment sessions. Furthermore, they did not include the number of CBT 
sessions received by participants as a factor in their analysis. In relation to this, 
although an intention-to-treat analysis was performed (using last observation carried 
forward) it was not clear as to the number of participants where this was applicable 
(i.e. the number of drop-outs). Despite these limitations, Laidlaw et al (2008) 
conclude that their results highlight that CBT poses an effective and acceptable 
alternative to pharmacotherapy in the treatment of late life depression.  
 
A more recent and larger scale study of 204 participants with depression by Serfaty et 
al (2009) addressed some of the limitations of the study by Laidlaw et al (2008) and 
used the same CBT treatment manual modified for older people. This study compared 
the effectiveness of CBT, TAU and a talking control condition (TC) offered over the 
course of four months with a maximum of 12 treatment sessions in the CBT and TC 
conditions. In the TC condition participants received sessions with a therapist who 
was instructed to provide interest and warmth towards the participant, but not to 
engage in any specific therapeutic techniques (such as challenging dysfunctional 
thoughts or giving any form of advice).  
 
The results of this study showed that, in comparison to the TAU and TC condition, 
those who received CBT showed statistically significant greater improvements in their 
symptoms of depression over the course of treatment, which were maintained at a 10 
month follow-up point. The authors conclude that their results highlight the direct 
effect of CBT in treating depression in older people and challenges any assumptions 





Furthermore, as all participants in this study were provided with treatment as usual, 
with no significant difference in the number of participants between each treatment 
group receiving concurrent antidepressant medication, this study has a degree of 
external validity, in terms of the combination of treatments that occur in typical 
clinical practice. Indeed, Laidlaw et al (2008) highlight that a factor that limited 
participation in their study was that some potential participants at recruitment were 
receiving antidepressants and some may have withheld consent to participate, due to 
the possibility of not being able to receive antidepressants. An interesting finding in 
the study by Serfaty et al (2009) was that only one fifth of participants who received 
antidepressants were prescribed a therapeutic dose, highlighting the importance of 
alternative non-pharmacological treatments for depression in older people.  
 
1.2.3 Myths Surrounding Psychological Treatment with Older People 
Despite the findings indicating equality in the efficacy of psychological treatments, 
and in particular CBT, between adults of working age and older people, there is 
evidence to suggest that older people often do not receive psychological treatments. 
Wei et al (2005), for example, found that only 25 per cent of older people with 
depression were provided with a psychological treatment and of these only 33 per 
cent remained in consistent treatment. Evidence also suggests that the percentage of 
older people receiving psychological treatment for depression and anxiety disorders is 
below what would be expected based on the prevalence rates for this population 
(Department of Health, 2011).  
 
This finding is of particular significance given the evidence to suggest that the main 




levels with older people due to factors such as concerns regarding poly-pharmacy and 
side-effects and the interaction such medications can have on physical health 
problems (McDonald, 1986; Crawford et al, 1998; Serfaty et al, 2009).  
 
Laidlaw et al (2003) highlight a number of ‘myths’ that surround psychological 
treatment with older people, which may influence whether or not they receive it. 
These myths follow two main themes with the first being ‘older people will not 
benefit from psychological treatment’. As mentioned above, despite there being 
relatively fewer studies with older people than adults of working age, the evidence 
suggests psychological treatments are equally effective in both age groups. This 
suggests it is inappropriate to deny older people psychological treatment on the 
assumption they will not benefit from it.  
 
The second theme relates to an assumption that ‘older people will not want 
psychological treatment’. A number of studies have, however, debunked the myth that 
older people prefer not to receive psychological treatments. Rokke and Scogin (1995), 
for example, compared older and younger adults’ attitudes to mental health services 
and treatments for mental health problems. The results indicated that, in comparison 
to younger adults, older people expressed more positive attitudes towards mental 
health professionals and both age groups gave equally positive ratings regarding the 
acceptability and credibility of CBT as a psychological treatment. Similarly, 
Landreville et al (2001) found that when given vignettes describing patients with 
depression and three different treatment options (Cognitive Bibliotherapy (CB), 
Antidepressant Medication (AM) and CBT) older people rated CB and CBT as being 




CBT was rated by older people as being more acceptable than CB and AM for 
treating severe depression. These studies therefore indicate a preference for 
psychological rather than pharmacological treatments amongst older people. A 
potential weakness of these studies is that they do not take into account patients 
preferences in relation to combined treatments.  
 
This issue was, however, addressed in a more recent study by Hanson and Scogin 
(2008), which compared older peoples preferences for CBT, Antidepressant 
Medication (AM) and combined CBT and AM (CBT+AM) for treating depression. 
The results indicated that, in relation to the general acceptability of the various 
treatment options, older people viewed CBT+AM to be a more preferable treatment 
than CBT or AM alone. However, when asked to consider possible negative aspects 
of the treatments, older people rated CBT as being preferable to either CBT+AM or 
AM.  These studies further emphasise the importance of psychological therapies as an 
important treatment option for older people.  
 
1.2.4 Conclusion 
The above section highlights that CBT is an effective and acceptable treatment for 
depression and anxiety in older people. However, despite a range of initiatives to 
increase access to psychological therapies such as CBT across the UK (DOH, 2011), 
there is growing evidence to suggest that older people are under-represented in 
services providing such treatment.  For example, a recent report by the Department of 
Health (DOH, 2011) and a previous study by Clark et al (2009) suggested that at 
present older people account for only 4 per cent of individuals who are treated within 




These studies suggested that, based on the prevalence rates of depression and anxiety, 
the expected rate of use of such services by older people should be 12 per cent. 
Similarly, Boddington (2011) proposes an ‘equality of access score (EOA)’ which 
involves dividing the percentage of older people seen in a service by the percentage of 
older people (relative to adults of working age) in a population, multiplied by 100. An 
EOA score of 100 would indicate older people gaining equal access to psychological 
treatment as adults of working age. Boddington (2011) examines EOA scores across 
five services from England and Scotland and highlights the range of EOA scores from 
15.3 to 48, with the highest score still remaining “disappointingly low” (p11) and 
providing further evidence that older people are not accessing psychological 
treatments. A study by Todman et al (2011) also highlighted that in a six month 
period GPs only made nine referrals to a clinical psychology service for older people. 
Furthermore, in a qualitative analysis Todman et al (2011) found that GPs, despite 
recognising depression and anxiety as problems for older people, which could benefit 
from psychological treatment, were reluctant to make referrals for such treatment due 
to perceptions of long waiting times and a lack of locally available resources (i.e. 
patients may have to travel long distances for treatment, which may be a particular 
issue with older people ,who may be less mobile). 
 
A further factor that may account for low rates of older people accessing 
psychological treatment may relate to the number of clinicians specialising in 
providing psychological treatments to older people, whereby a lack of trained 
therapists in general has been highlighted as a factor limiting access to psychological 
treatment in people of all ages (Layard et al, 2006; Shafran et al, 2009; Andrews & 




services that have appointed more staff with a special interest in treating older people 
or services with clear pathways to specialist older people psychology services. Wells 
et al (2010) suggest that 19 wte applied psychologists are required for every 100 000 
of the population. However, across Scotland there are currently only 0.6 wte applied 
psychologists per 100 000 of the population specialising in working with older people 
(Wells et al, 2010). This indicates that the lack of available therapists is a particular 
issue with older people.  
 
All the studies mentioned above recommended that older people need to have better 
access to psychological therapies. Whilst increasing the numbers of clinicians 
specialising in providing psychological treatments for older people would be a 
welcome addition to achieving this, in the current economic climate the possibility of 
this happening to the levels required may not be realistic. Therefore, alternative and 
innovative methods of increasing the provision of psychological treatments are also 
required.   
 
1.3 COMPUTERISED COGNITIVE BEHAVIOUR THERAPY (CCBT) 
1.3.1 Introduction to CCBT 
The preceding sections highlight CBT as an effective treatment for dealing with the 
high prevalence of depression and anxiety in older people. It has also been highlighted 
that there are a number of potential difficulties in patients being able to access this 
type of treatment. One of the factors that limits access and is relevant to all age groups 
relates to the lack of trained therapists. This may be a particular issue in relation to 
older people, where in comparison to adult services, there are less available specialist 




al, 2010). There has therefore been a focus on the development of alternative ways of 
delivering CBT from the traditional face-to-face method, which (due to its typical 
requirements of 6-20 sessions lasting 45-60 minutes, with one therapist per patient per 
session) has been described as “labour-intensive” (Van Den Berg et al, 2004). 
Alternative, less labour-intensive methods, potentially offer the opportunity to deliver 
CBT to larger numbers of patients, but are only viable if they are found to be effective 
and acceptable to patients. Such treatments also fit in with matched models of care 
advocated by the NICE guidelines for the treatment of depression (NICE, 2009), 
whereby individuals with less severe levels of depression should first be provided 
with ‘low intensity treatments’ and those failing to respond to these treatments (or 
with more severe levels of depression) can be provided with ‘high intensity 
treatments’.  
 
A recent innovation in terms of alternative methods for delivering CBT has been the 
development of Computerised Cognitive Behaviour Therapy (CCBT). Cavanagh and 
Shapiro (2004) highlight that for a number of years attempts have been made to 
transfer the “key ingredients” of psychological treatment into computer programs that 
deliver such treatment and do not require (or significantly reduce the need for) the 
presence of a trained clinician to deliver the treatment. Proudfoot et al (2003a) argue 
that CBT, which has an emphasis on short-term treatment that is present-focused, 
structured, involving psychoeducation and clear procedures for patients being taught 
skills to manage their symptoms, lends itself well to having some of the key features 
of the treatment replicated and delivered in a computer program. Furthermore, 
Cavanagh and Shapiro (2004) suggest that recent developments in multimedia 




which have been identified as important factors that influences outcomes from CBT, 
can be much more effectively replicated by contemporary computer technology. 
These components include: the therapeutic alliance, empathy, communicating hope 
for improvement, increasing patient motivation and providing feedback on homework 
tasks. Cavanagh and Shapiro (2004) suggest that the features of the latest CCBT 
packages allow these aspects to be incorporated.  Proudfoot et al (2003a), suggest that 
it was the lack of emphasis on incorporating such therapeutic features and instead 
focusing simply on “transposing words from a treatment manual to a computer 
screen” that meant previous attempts at delivering computerised therapy failed.  
 
A number of different CCBT packages have now been developed and potentially offer 
one method of increasing access to psychological therapies. Within matched care 
models of service delivery, as advocated by NICE, CCBT packages are often 
described as ‘low intensity’ treatments. The programs primarily have an emphasis on 
self-help whereby patients independently complete the sessions contained in the 
computer programs with much more limited contact with a therapist. Such packages 
can therefore be offered to a large number of patients as a first line treatment, whilst 
significantly reducing the requirement of a therapist to be available. Following 
completion of the CCBT program, only those subsequently requiring more intensive 
treatment are referred on to higher intensity treatments (e.g. face–to–face CBT).   
 
1.3.2 Examples of CCBT Packages 
A number of different CCBT packages have now been developed.  Some packages 
have been designed to be used as an adjunct to face-to-face treatment (e.g. Good Days 




program, therefore, does not directly fit in with a stepped-care model to improve 
access to psychological treatments.  
 
Three systematic reviews of the literature (Kaltenthaler et al, 2004; Kaltenthaler et al, 
2006; Kaltenthaler et al, 2008) on the use of CCBT have identified seven different 
software packages for the treatment of depression and anxiety. These include Beating 
the Blues (Proudfoot et al, 2003a); Overcoming Depression: A Five Areas Approach 
(Whitfield et al, 2006); FearFighter (Shaw et al, 1999); MoodGym (Christensen et al, 
2004); Overcoming Depression on the Internet (Clarke et al, 2005); COPE (Osgood-
Hyness et al, 1998); and BTSteps (Griest et al, 2002). Each of the cited papers 
provides a description of the packages in more detail.  
 
The Technology Appraisal Guidelines on the use of CCBT (NICE, 2006) reviewed 
the evidence for the range of CCBT packages available for the treatment of 
depression and anxiety in terms of their clinical and cost-effectiveness. Beating the 
Blues (BTB) was the only package that was recommended, as both a clinical and cost-
effective intervention for the treatment of depression, whilst Fearfighter was 
recommended as an effective package for treating phobias.  It was concluded that the 
other packages reviewed did not yet have a sufficiently established evidence-base for 
supporting their use. These recommendations were maintained in the NICE guidelines 
for depression (NICE, 2010).  A limitation of the reviews of CCBT mentioned above, 
which the authors have highlighted, has been that there are relatively few outcome 
studies of sufficient quality at present to draw any firm conclusions about the efficacy 
of other CCBT packages. For example the NICE guidelines on depression identified 




1.3.3 Review of Evidence for Beating the Blues 
A review of the literature was conducted to identify the evidence-base of studies 
purporting to show the effectiveness of BTB and to identify gaps in the literature. The 
criteria for inclusion in the review were kept broad; all randomised control trials and 
non-comparator open trials of BTB, which reported outcome data on participants 
symptoms of depression or anxiety were included. The studies were identified through 
4 different means. Initially, searches were made of several electronic literature 
databases including: Medline; PsycINFO; the Cochrane Database; and 
PsycARTICLES. Search items included combinations of the following disorder and 
intervention terms, using truncated versions and different spellings: anxiety or 
depression with; cognitive therapy, or behaviour therapy, or, CBT, or psychotherapy, 
or intervention, or treatment; with computer or computerised or internet. These 
searches were supplemented by using ‘Beating the Blues’ as a search term. Secondly, 
the developers of BTB (Ultrasis) were contacted to request a reference list of all the 
BTB studies that, to their knowledge, had been completed or were ongoing. Thirdly, 
the reference sections of the systematic reviews and meta-analysis of CCBT, cited in 
section 1.3.2, were inspected, together with the reference lists of initially identified 
studies, to locate possible additional papers for inclusion in the review. Lastly, 
individuals who had previously conducted research on BTB and individuals with 
expertise in the field of CBT were contacted regarding their knowledge of previous, 
recently completed and ongoing studies of BTB. All identified studies were cross 
referenced.  
 
The abstracts of all the identified studies were initially evaluated to determine whether 




did not meet the inclusion criteria (e.g. it was clear it was not reporting on the 
outcome of receiving BTB) it was removed from further analysis. Whenever any 
doubt arose from the initial review of the abstract as to whether the study met the 
inclusion criteria the full text was obtained to complete a fuller evaluation. The full 
text of all the remaining studies were subsequently evaluated to determine whether 
each study met the inclusion criteria. A total of 11 studies were identified (three RCTs 
and eight other studies). These are critically evaluated below. 
 
1.3.3.1 Evidence from Randomised Controlled Trials (RCTs) 
An initial beta test by Proudfoot et al (2003a) demonstrated that, for a sample of 20 
participant’s experiencing depression, BTB produced significant reductions by the end 
of the treatment on measures of depression, anxiety and work and social adjustment. 
Although there were a number of limitations in this pilot study, such as a lack of a 
control group and a drop out rate of over 50 per cent, with no intention-to-treat (ITT) 
analysis being performed, the authors conclude that participant feedback about BTB 
was positive and the results were promising enough to evaluate BTB further in a larger 
scale RCT. The first RCT of BTB was conducted by Proudfoot et al (2003b). In this 
study, 167 patients attending their GP were recruited and randomly allocated to either 
BTB (N = 89) or GP treatment as usual (TAU, N = 78). Patients suffering from 
anxiety and/or depression, as assessed by the Computerised Clinical Interview 
Schedule – Revised (CIS – R, patients scoring > 12) were included. Patients in the 
BTB group received eight sessions of BTB and were also provided with GP treatment 
as usual. The only constraint that was placed on the treatment as usual the BTB group 
could receive was that no “face-to-face counselling or psychological intervention” (p 




randomised between the two groups in the study. No constraints were placed on the 
treatment participants in the TAU group received and in addition to medication this 
included “discussions with GP, provision of practical/social help and referral to 
specialist mental health professionals” (Proudfoot et al, 2003b p 219).  
 
The results of the study indicated that at the post-treatment assessment point those in 
the BTB group showed significantly greater improvements than the TAU group on 
measures of depression, anxiety and work and social adjustment (Proudfoot et al 
2003b). These improvements were maintained at one, three, and six month follow-up 
points and the authors argue that these findings were independent of the duration and 
severity of illness prior to treatment and whether or not participants received 
psychotropic medication. The authors highlight that a weakness of their study was 
that the sample size did not allow more definitive conclusions to be drawn about these 
latter factors.  
 
A subsequent study by Proudfoot and colleagues (Proudfoot et al, 2004) continued 
their previous research whereby a further 105 patients were randomised to BTB (N = 
55) or TAU (N = 50). The results of this second study of 105 patients replicated the 
findings of the initial study by Proudfoot et al (2003b), whereby in comparison to the 
TAU group those receiving BTB showed significantly greater reductions on measures 
of depression, anxiety and work and social adjustment. The authors subsequently 
combined the sample of this second study with the participants in the initial study by 
Proudfoot et al, (2003b). The authors argue that this larger sample allowed them to 
demonstrate more robustly that the results were independent of whether patients 




treatment. A limitation of these two studies was they did not report effect sizes or 
provide an analysis of the clinical significance of their findings (e.g. the percentage of 
patients in each group meeting criteria for clinically significant improvements) as this 
has been advocated as more meaningful when drawing conclusions about the 
relevance of a treatment to actual practice (Jacobson and Truax, 1991).  
 
A further weakness of both these studies is that although they evaluated the 
acceptability of the BTB treatment and concluded it was an acceptable treatment, this 
was based only on rates of drop-out and self-reports of satisfaction with treatment. 
This latter factor was however only with patients who had not dropped out of the 
study, which may provide biased results. Uptake of treatment would also be an 
important factor determining the acceptability of a treatment, although this was not 
addressed by Proudfoot et al (2003b) or Proudfoot et al (2004). It was evident in the 
study by Proudfoot et al (2003b) that of the 167 individuals recruited to the study a 
further 100 refused to participate, giving a refusal rate of 41 per cent. It is feasible that 
the possibility of randomisation to BTB contributed to the refusal of these individuals 
to take part in the study and would indicate it being an unacceptable treatment for a 
significant proportion of patients, limiting whether the results can be generalised to 
the wider population. An alternative explanation could be that individuals refusing to 
participate would not wish to take part in any study regardless of the treatment. Based 
on the results provided, it was not possible to draw any conclusions about reasons for 
non-participation.  
 
A further weakness of these two studies is that, although they report the inclusion 




deviations of the samples age (BTB = 43.7 (SD – 14.7) and TAU = 45.7 (SD – 14.1). 
This would therefore exclude a significant proportion of older people (those over 75) 
and based on the mean and standard deviation of the samples age, older people overall 
may have been under represented. This makes it difficult to determine if these results 
can be generalised to older people. 
 
Grime (2004) conducted an RCT exploring the effectiveness of BTB plus 
‘Conventional Care’ (BTB) to ‘Conventional Care’ alone (CC) in the treatment of 
work related stress, anxiety and depression. This study also aimed to evaluate the rate 
of uptake into the study and the reasons given by individuals for non-participation. 
Participants were included if they had 10 or more cumulative day’s absence from 
work as a result of stress, anxiety or depression, and scored above 4 on the GHQ-12. 
 
The results indicated that of the 155 patients approached about taking part and 
meeting the inclusion criteria, only 48 agreed to participate (30.9 per cent uptake 
rate), with 24 in the BTB group and 24 in the CC group. Of the 107 people who 
declined to participate, 60 provided reasons for this. It was apparent that the primary 
reasons for non-participation related to difficulties in meeting the demands of the 
study itself, irrespective of what the treatment consisted of. For example, twenty 
participants reported that it would be too difficult to travel to the location where the 
BTB sessions took place, thirteen reported they would be unable to take time off work 
to participate, and thirteen were unhappy that their employer would be aware of their 
participation. A minority reported reasons relating to negative perceptions about BTB. 
For example, twelve individuals reported that they did not think the BTB treatment 




negative perception of the BTB treatment itself did not form the main reason why such 
a large proportion of patients declined to take part. The other reasons are, however, 
important factors that would have to be considered in terms of the utility of the BTB 
treatment in actual clinical practice.  
 
In terms of drop-out, 16 (66.7 per cent) participants in the BTB group completed all 
eight sessions, whilst eight (33.3 per cent) dropped-out, although 4 of the drop-outs 
completed the post-treatment outcome questionnaires. No participants in the CC 
group dropped-out by the post-treatment assessment point. No analysis was made 
regarding factors that may have influenced drop-out from BTB.  
 
In terms of outcome, the results indicated that in comparison to the CC group those in 
the BTB group showed statistically significantly reductions in depression scores on 
the Hospital Anxiety and Depression Scale (HADS) and on the Attribution Style 
Questionnaire by the end of the eight-week treatment, which indicated a significantly 
greater improvement in their symptomatology. At the one month follow-up, 
participants in the BTB group also showed statistically significant greater reductions 
in anxiety as well as depression on the HADS than the CC group. At the three and six 
month follow-up points there were no statistically significant differences on any of the 
measures between the BTB group and the CC group, although the author highlights 
that due to study attrition in the two groups by these assessment points too small a 
sample was available to detect a statistically significant difference. As with the earlier 
RCTs by Proudfoot et al (2003b) and Proudfoot et al (2004), this study did not report 




outcome, reducing the conclusions that can be drawn in terms of the importance of the 
statistical findings to actual clinical practice. 
 
There are also a number of methodological weaknesses in this study. The analysis did 
not employ an ITT analysis (i.e. four participants in the BTB group who started the 
treatment but did not complete post-treatment outcome measures were not included in 
the analysis). Although this was a relatively small number, these participants may 
have shown a large deterioration in their symptoms (which could have explained their 
withdrawal) which may have reduced the magnitude of change found in the BTB 
group. This, therefore, does not take into account the impact of treatment drop-out on 
the overall effectiveness of BTB. 
 
Furthermore, a major confounding factor relates to the conventional care both groups 
received as part of the study. It was apparent that those in the BTB also received 
active psychological treatments in addition to BTB as part of their conventional care. 
For example, 11 participants in the BTB group received face-to-face psychological 
treatment, such as Solution-Focused Therapy, whilst 12 in the CC group received 
such a treatment. In addition, four participants in the BTB group were provided with 
“other care” as part of their conventional treatment, although it was not specified what 
this consisted of. Although it was approximately equal in terms of the number of 
participants receiving such conventional care between the two groups, it was not 
reported how much treatment each participant received (i.e. how many sessions had 
been attended). It would be possible that those in the BTB group attended a greater 




which may account for the changes between the two groups, rather than specifically 
the BTB treatment as being the variable producing changes.   
 
A further limitation of the study was that the age range of the participants was not 
reported but only the mean and standard deviations (BTB = 41 (SD = 10.83) and CC = 
37 (SD = 8.27). Taking into account the mean ages, and as this study was based 
within a work place occupational health department it could be surmised that older 
people may not have been included in this study, making it difficult to generalise 
these findings to older people.  
 
1.3.3.2 Evidence from Non Randomised Controlled Trials 
A study by Van Den Berg et al (2004) described the implementation of BTB within a 
community mental health team (CMHT). This study explored the effectiveness of 
BTB within the everyday practice of the CMHT, whereby the results of the Clinical 
Outcomes in Routine Evaluation questionnaire (CORE) were compared pre-treatment 
and post-treatment amongst a cohort of 13 participants receiving BTB.  
 
It was not possible to evaluate the rate of uptake from BTB in this study, as they did 
not report exact figures relating to how many were offered BTB. The authors, 
however, state 60-70 per cent of their referrals may benefit from BTB, whilst of these 
about 50 per cent agreed to start BTB.  There was an indication that 115 patients had 
used BTB within the service but it seemed that the 13 who actually participated in the 
study were included on the basis that they were the only ones that had completed pre- 
and post-CORE measures. The authors also report approximately 45 per cent of 




treatment outcome, the results suggested that, in comparison to the start of treatment 
there was a statistically significant reduction in scores on the CORE by the end of 
treatment (effect size, = 1.1)
4
. These results were not, however, maintained in a sub-
sample of nine participants who completed a six month follow-up assessment. 
 
These results should, however, be treated with caution as it was a small sample and 
there was no control condition. In relation to this, the authors did not report on the 
effects of any concurrent psychotropic medications or face-to-face psychological 
treatments participants may have been receiving, meaning it is difficult to establish 
the extent to which the results are attributable to BTB. In addition, the study did not 
include any specific standardised assessment of depression and anxiety with this 
cohort, making it difficult to generalise these finding to these specific problems.  A 
further weakness was that the age of the participants was not included, making it 
difficult to draw any conclusions about whether these results can be generalised to 
older people.  
 
Hunt et al (2006) examined the integration of BTB into a stepped care, primary care 
mental health service. A total of 54 participants were reported to have completed BTB 
and (in comparison to the start of treatment) by the end of treatment there was a 
significant reduction in participants scores on measures of depression and social 
adjustment. The authors also argue that the vast majority of participants found BTB to 
be “enjoyable, easy and pleasant to access and helpful in overcoming their 
depression” (p34).   
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Cavanagh et al (2006) examined the effectiveness of BTB in routine primary and 
secondary care practice. This was conducted in eight general practices, two 
community mental health teams and one primary care clinical psychology service all 
of which had incorporated BTB into their respective services. A total of 219 
participants commenced BTB during the time frame of the study, with an age range of 
16 – 70 years. Participants were included in the study if: 1) they were referred to any 
of the eleven services for the treatment of depression and/or anxiety; 2) if they were 
assessed as likely to benefit from BTB; and 3) if they scored four or above on the 
General Health Questionnaire (GHQ – 12). The study used the Clinical Outcomes in 
Routine Evaluation (CORE) and the Work and Social Adjustment Scale (WSA) prior 
to treatment, post-treatment and at six month follow-up, to assess the effectiveness of 
the BTB.  
 
It was not reported how many patients who were offered BTB declined to receive this 
treatment, meaning it was not possible to evaluate the uptake of BTB in this sample. 
Of the 219 patients who commenced BTB, 135 (61.6 per cent) completed all eight 
sessions (38.4 per cent dropped-out) and of these treatment completers, 104 
completed the post-treatment outcome measures with a further 40 completing the six 
month follow-up outcome measures. The results showed no significant differences 
between those who completed treatment and those who dropped out on a range of 
demographic variables (e.g. age, gender, computer experience etc) or illness variables 
(e.g. scores at pre-treatment on the CORE or WSA). 
 
In terms of the effectiveness of the treatment, the results of those completing all eight 




significant reductions on both the CORE (effect size = 1)
5
 and WSA (effect size = 
0.5). The authors also completed an intent-to-treat (ITT) analysis using the last 
observation carried forward method (LOCF) to take into account the effects of 
individuals dropping out of the study. Whilst this more conservative method of 
analysis produced an expected reduction in the effect sizes of the BTB treatment, the 
results still showed a statistically significant reduction in patients scores on the CORE 
(effect size = 0.5) and WSA (effect size = 0.26) between the start and end of 
treatment. These improvements were maintained at six month follow-up in the sub-
sample of 40 patients who completed these follow-up measures.  
 
These latter results have to be treated with caution as not only was there a relatively 
large attrition rate in the numbers of participants completing the six month follow-up 
measures, but the authors also did not examine any subsequent treatment that was 
received during this follow-up period that could potentially account for the 
maintenance of improvements. In relation to this, the authors did not report on any 
psychotropic medications or concomitant psychological treatment participants may 
have been taking throughout the study, which could be significant confounding 
factors influencing the results. This weakness is further highlighted by the lack of a 
control group, making it difficult to determine how much the results were attributable 
specifically to BTB.  
 
A further weakness of this study was that it did not employ any specific standardised 
measures for depression and anxiety, making it difficult to generalise the findings to 
these specific problems. Cavanagh et al (2006), however, argue that the use of the 
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CORE allows benchmarking of the results of their study to the national database of 
CORE outcomes for primary and secondary care psychological therapies services in 
the UK (Barkham et al 2005). Cavanagh et al (2006) suggest that their results show a 
pre-post effect size smaller than what is typically found in primary care services, but 
larger than what has been found in secondary care services. They also suggest the 
drop-out rates for BTB in their study are similar to what is found in face-to-face 
psychological treatments. Despite the limitations of the study, Cavanagh et al (2006) 
therefore concluded that their pragmatic study suggests that BTB is a useful first line 
treatment for common mental health problems, such as anxiety and depression, in 
everyday clinical practice. Of note, however, is the fact that the mean age of 
participants was 43 years (SD = 11.7), which suggests that a significant proportion of 
older people (i.e. those over 70 years) were excluded from the study and the minority 
aged 65-70 years that were included may have been under-represented. This makes it 
difficult to generalise the findings to older people. 
 
A study by Mitchell and Dunn (2007) examined the use of BTB in a sample of 12 
higher education students experiencing symptoms of depression as assessed by 
scoring above twelve and above on the Beck Depression Inventory (BDI). The 
authors state that everyone who met the inclusion/exclusion criteria agreed to start 
BTB, suggesting a 100 per cent uptake rate, although the 12 who were recruited 
represents a relatively small number. The results indicated 10 participants completed 
all eight sessions (83.3 per cent), whilst two (16.7 per cent) dropped out after sessions 
three and four, respectively. Due to the small numbers, no detailed analysis was 
reported regarding factors that influenced drop-out, other than one participant 




participants completed pre-treatment and post-treatment outcome measures. These 
eight participants showed a statistically significant reduction in their symptoms of 
depression by the end of treatment, as assessed by the BDI (effect size r = 0.63). 
There was, however, no significant difference in anxiety as assessed by the Beck 
Anxiety Inventory (BAI).  
 
These findings should, however, be treated with caution, particularly as: 1) it was a 
relatively small sample; 2) only the results of those completing all eight sessions and 
the post-treatment outcome measures were analysed (representing only 66.7 per cent 
of the initial sample recruited); 3) there was no control group against which to 
compare the results of the treatment; and 4) no longer term follow-up data were 
reported. Despite these weaknesses, the authors conclude that BTB was an effective as 
well as a credible and acceptable treatment for this small sample of participants 
(Mitchell & Dunn, 2007).  
 
Learmonth and Rai (2007) examined the effectiveness of BTB in treating individuals 
with symptoms of depression and co-morbid physical health problems, such as 
Irritable Bowel Syndrome, headaches and Chronic Fatigue Syndrome. The results 
indicate that, in comparison to a waiting list control group, patients with and without 
physical co-morbidities showed equally greater reductions in symptoms of depression 
after completing BTB. A further study by Learmonth and Rai (2008) explored the use 
of BTB with 104 patients who had been referred to a specialist CBT service for the 
treatment of chronic depression and/or anxiety (median duration 5 – 10 years), but 
were currently held on a waiting list for face-to-face treatment. No assessment was 




from the study but they were excluded if they were actively suicidal, had a primary 
diagnosis of obsessive compulsive disorder, had drug or alcohol dependence, 
cognitive impairment, were ambivalent about treatment, or were currently receiving 
face-to face psychological treatment.  
 
Learmonth and Rai (2008) do not report in detail the uptake of BTB and factors that 
may influence this, but they do suggest 75 per cent of patients agreed to start BTB 
suggesting this was the uptake rate.  Of these 104 participants, 71 (68.3 per cent) 
completed all eight sessions of BTB, whilst 31 (31.7 per cent) dropped out of 
treatment after completing a mean of 3.8 sessions. There were no significant 
differences between completers and those who dropped-out with regard to age, gender 
or pre-treatment scores on the CORE. No other factors in terms of drop-out were 
explored. 
 
In terms of outcome, those who completed all eight sessions showed a statistically 
significant improvement by the end of treatment on the CORE questionnaire (effect 
size = 1.26). The authors also used an ITT analysis using the LOCF method to take 
into account those who had dropped out of treatment. This analysis also produced a 
statistically significant pre/post reduction on the CORE by the end of treatment (effect 
size = 0.82). The authors conclude that, as almost 50 per cent of those completing 
BTB also met criteria for clinically significant improvement, their findings suggest 
BTB has the potential as an initial treatment option that patients can quickly access. 
 
There were, however, a number of weaknesses in the study, including the lack of a 




ruled out. The authors argue that spontaneous recovery or benefits from psychotropic 
medication would be unlikely in their sample, as many had been waiting for several 
months prior to commencement in the study and reported a chronic duration of 
symptoms. However, the study, did not include a minimum level of symptomatology 
required for inclusion in the study suggesting that some could have already remitted 
but were still keen to take part in the study. The study also did not employ a 
standardised measure of depression or anxiety in their assessment of treatment 
outcome, making it difficult to generalise the findings to these specific problems. 
Lastly, the study reported the age range of participants was 19 – 70 years old (Mean 
39, SD = 11.6). This suggests a significant proportion of older people (those over the 
age of 70 years) were not included in the study, and those between the age of 65-70 
years that were included, were in the minority. Clearly this makes it difficult to 
generalise the findings of this study to older people.  
 
A naturalistic study by Learmonth et al (2008) reported the results of 555 patients 
aged between 18-70 years who were referred, over a 60 month period, to a specialist 
CBT centre for the treatment of anxiety and/or depression. Patients who were on the 
services waiting list (reported to be 12-18 months from referral to treatment) for face-
to-face CBT were assessed by a CBT therapist and offered the opportunity to use BTB 
whilst waiting for face-to-face treatment. Participants were included if they were 
assessed as likely to benefit from BTB and were excluded if they were actively 
suicidal, had a primary diagnosis of obsessive-compulsive disorder, had drug or 
alcohol dependence or cognitive impairment, or were currently receiving face-to-face 




the specialist CBT centre and were assessed again by a CBT therapist 6-8 weeks after 
completing BTB and offered further treatment if required.  
 
The results indicated that 829 patients were offered BTB and 555 agreed to 
participate, giving an uptake of 67 per cent. Of those who started BTB, 394 (71 per 
cent) completed all eight sessions with 161 (29 per cent) dropping out after a mean of 
3.5 sessions. No significant differences were found between those who completed all 
eight sessions and those who dropped out, in terms of demographic details, anxiety 
and depression severity, or duration prior to starting BTB. In terms of clinical 
outcome, the results indicated that those completing all eight BTB sessions showed 
statistically significant reductions by the end of treatment in their symptoms of 
depression and anxiety, as assessed by the Beck Depression Inventory (BDI) and 
Beck Anxiety Inventory (BAI), with effect sizes of 0.85 and 0.55 respectively.  
 
An ITT analysis, incorporating those who dropped out of treatment, using LOCF 
again showed statistically significant reductions by the end of treatment on the BDI 
and BAI, although the effect sizes had reduced to 0.72 and 0.5 respectively.  
Furthermore, the authors report that 21 per cent of participants in the ITT sample 
achieved a clinically significant improvement in their symptoms of depression and 19 
per cent achieved this in their symptoms of anxiety. The percentage of participants 
achieving clinically significant improvement was elevated to 23 per cent and 26 per 
cent for anxiety and depression, respectively, in the completers sample. Lastly, the 
results indicated that of those completing BTB 21 per cent required follow-up, face-to-
face psychological treatment ,whilst 95.5 per cent of those dropping-out required this. 




after starting BTB was 3.5, which they suggest is smaller than the 15 sessions their 
service typically provides.  
 
There were, however, a number of methodological weaknesses in the study. Firstly, 
although 555 participants were recruited and started BTB, it appeared that data 
relating to depression and anxiety symptoms from only 241 and 252 participants 
respectively were entered into the completer analysis, whilst a significantly higher 
number of participants (394) were reposted to have completed the treatment. 
Similarly, in their ITT analysis, only data relating to depression and anxiety 
symptoms for 298 and 301 respectively were included, rather than the 555 which 
should have been included in an ITT analysis. It was not made clear in the report what 
happened to these lost data in both their completer and ITT analysis, which could call 
into question the validity of the results of the study (i.e. it is possible that all of the 
participants who did not have outcome data entered into the analysis significantly 
deteriorated in terms of their symptoms).  
 
A further weakness is the lack of a control group, which makes it difficult to conclude 
that the results can be attributed to the BTB treatment rather than other external 
factors. Related to this point, although an exclusion criterion was that participants 
were not receiving concurrent face-to-face psychological treatment at the start of the 
study, the authors made no mention about concurrent psychotropic medication usage, 
which could have been a significant confounding factor influencing the results (i.e. it 
is possible participants improved as a result of their GP prescribing antidepressants 
and this accounted for the results). Similarly, it was clear that 22.4 per cent of 




face psychological treatment. However, it was not clear whether or not participants 
had started this prior to the post-BTB assessment, which took place up to two months 
after completing BTB. It is possible participants may have begun face-to-face 
treatment by the post-BTB assessment, which may have also confounded the results. 
A final limitation of the study was that although the age range of participants was 18-
70 years, the mean was 40 years (SD = 12), suggesting that a significant proportion of 
older people were excluded (those over 70 years) and that those who were included 
may have been under-represented. This makes it difficult to generalise these findings 
to older people.  
 
A recent naturalistic study by Cavanagh et al (2011) explored the use of BTB in a 
service-user led self-help clinic, which accepted both primary care and self-referrals 
for anxiety and/or depression. During the 16 month timeframe of the study, 510 
referrals were received and if individuals were assessed as being suitable they were 
offered BTB within seven days at a community venue. It was not made clear what the 
inclusion/exclusion criteria were, or how participants were assessed as “being 
suitable”, but it was reported that five referrals were deemed unsuitable. A further 78 
potential participants (15.3 per cent) did not attend the initial assessment interview.  
 
The results indicated that of the 432 individuals who attended an initial appointment 
with the service, 295 were considered appropriate and went on to complete initial 
outcome measures and start the first session of BTB, giving an uptake rate for BTB of 
68.2 per cent. Of these patients 265 (89.8 per cent) completed at least two sessions of 
BTB whilst 156 (52.9 per cent) went on to complete the full eight sessions (47.1 per 




significantly more likely to start BTB, complete at least two sessions, and go on to 
complete the full eight sessions, when compared to those referred by a primary care 
service. The results also indicated no significant differences in terms of uptake or 
drop-out from BTB in terms of gender, ethnic group, use of psychotropic medication, 
presence of chronic physical health problems, or age. The results also found no 
significant difference in terms of uptake regarding baseline levels of depression, 
anxiety, general well-being or work and social adjustment. However, intake level of 
symptomatology was found to be significantly lower in those completing the full eight 
sessions compared to those who dropped out early.  
 
In terms of outcome, an ITT analysis using LOCF for participants completing at least 
two sessions of BTB found statistically significant reductions in symptoms of 
depression (effect size = 0.8), anxiety (effect size = 0.9), work and social adjustment 
(effect size = 0.4) and on the CORE (effect size = 0.6) questionnaire by the end of 
treatment (Cavanagh et al, 2011). In addition, the authors suggest following treatment 
50 per cent of the sample no longer met ‘casesness’ for either depression or anxiety 
(as assessed by scoring below clinical cut-offs on self-report measures of depression 
and anxiety). The authors argue their results are comparable to the outcomes found in 
two IAPT self-help services and conclude that their study supports the use of BTB and 
the development of further service-user led self-help services for treating common 
mental health problems.  
 
There were, however, methodological weaknesses in this study, which means the 
authors conclusions should be treated with a degree of caution. The lack of a control 




attributable to BTB rather than other external factors. The authors argue that 
spontaneous recovery is not likely and therefore downplay this limitation. However, 
they did not report on, or take into account, the possibility of the effects of other 
treatments participants could potentially be receiving, such as the effect of concurrent 
medication and psychological treatment.  There was also no longer-term follow-up 
data reported, which means it is not possible to draw any conclusions regarding the 
sustainability of the results. In addition, only two participants in the study were over 
the age of 65 years, which limits the extent to which the results can be generalised to 
older people.  
 
1.4.4.3. Summary of Evidence for BTB 
The use of BTB has been supported by three RCTs and eight pragmatic studies of its 
use in routine clinical practice, all of which have been critically evaluated above. An 
aspect of the eight pragmatic studies that were reviewed has been that, whilst the 
results have consistently suggested that participants who received BTB showed 
significant reductions in their psychopathology by the end of treatment, only one 
study (Learnmonth and Rai, 2007) utilised a control group. Therefore, this limits any 
conclusions that can be drawn about the extent to which the findings in these studies 
were a direct result of participants receiving BTB (i.e. other factors that were not 
controlled for may have also influenced the results). 
 
The three RCTs, which were reviewed (Proudfoot et al, 2003b, Proudfoot et al, 2004 , 
and Grime, 2004)  have also consistently found that, in comparison to treatment as 
usual (the control group used in these studies), participants who also received BTB 




in their symptoms of anxiety and/or depression by the end of treatment. The use of 
random allocation of participants to either the intervention or the control group in 
these three studies allows stronger conclusions to be drawn about the beneficial 
effects of receiving BTB. However, as discussed above, the study by Grime (2004), in 
particular, had other confounding variables, which may have also influenced the 
results (e.g. participants in the BTB group were also provided with face-to-face 
psychological treatment). 
 
In addition, despite the evidence purporting to the beneficial impact of BTB for 
depression and anxiety, only four of the eleven studies that were reviewed reported on 
the clinical significance of the obtained results (Cavanagh et al, 2006; Cavanagh et al, 
2011; Learmonth and Rai, 2008); Learmonth et al, 2008) with none of the RCTs 
discussing this issue. This limits the conclusions that can be drawn about the clinical 
effectiveness of BTB, which has implications in terms of its viability for use in actual 
practice.  
 
One of the major limitations of all the studies that were included in the review was the 
apparent lack of older people who participated. Some studies (Grime, 2004; Mitchel 
& Dunn, 2007) were specifically targeting populations that would be unlikely to 
include older people (i.e. they specifically targeted working age adults and students 
respectively), whilst all the others studies either imposed an upper age limit of 70 
years or did not report on the age of participants. Although these studies could have 
potentially included some older people (e.g. those aged between 65-69 years), based 
on the mean ages of participants that were reported, it appeared that older people 




studies focused solely on older people. This means that any conclusions about 
whether the findings can be generalised to older people should be treated with 
caution.  
 
Given the lack of research that has focused the use of BTB with older people, not only 
are questions raised about whether it is an effective treatment for this population an 
important initial question would also be: is it an acceptable and therfore feasible 
treatment for older people?  Indeed, Elsegood and Powell (2008) have suggested that 
the lack of research focusing on the use of BTB with older people has been in part a 
result of assumptions that older people will not accept this treatment. The exploration 
of the acceptability of CCBT has been highlighted as an area in need of further 
research by Kaltenthaler et al (2008) and given the issues raised by Elsegood and 
Powell (2008) this would appear to be a pertinent area in relation to older people in 
particular.  
 
1.4 SUMMARY AND CONCLUSION  
The discussion in the sections above have highlighted that depression and anxiety are 
prevalent psychological problems amongst older people. With the aging population 
there is the potential that the demand for treatments for these disorders will increase 
amongst older people in the coming years. Psychological treatments, particularly 
CBT, have been found to be effective for older people and the evidence suggests that 
they find such treatments acceptable. Despite these facts, services specialising in the 
psychological treatment of older people are significantly under-resourced, and at 




associated with an ageing population.  CCBT offers one potential method to begin to 
help address this issue. 
 
1.5 RATIONALE OF CURRENT STUDY 
Despite evidence purporting to the acceptability and effectiveness of BTB with adults 
of working age, as discussed above, it appears that no study to date has specifically 
explored the use of BTB solely with older people in actual practice. It is therefore not 
possible at present to generalise the findings relating to the use of BTB to older 
people. Furthermore, the lack of research focusing on BTB with older people raises 
important, initial questions, about whether this will be an acceptable, and therefore 
viable, treatment for older people. The current study will therefore go towards 
beginning to address these major gaps in the literature and will be the first study, to 
the best of the author’s knowledge, to explore the acceptability and feasibility of BTB 
in actual practice with older people experiencing depression and anxiety.  
 
The specific focus on older people in the current study,  combined with the previous 
research with adults of working age, will also contribute to one of the research 
recommendations outlined in the NICE guidelines on the use of CCBT (NICE, 2006): 
that future research should explore whether such packages can be used effectively by 
people of all ages. The study will help inform whether BTB, in its present format, 
offers one potential option to help address the psychological needs of older people in 
the context of under-resourced older people mental health services.  
 
As highlighted previously, treatment acceptability is one of the major factors that will 




2008). It could be argued that other factors, such as the cost-effectiveness of BTB, or 
process issues relating to patients experience of using the treatment, would also be 
important areas relating to the viability of its use in actual practice.  However, 
Elsegood and Powell (2008) have highlighted that examining the acceptability of BTB 
may be particularly relevant with older people and an important first step in 
determining the treatments viability with older people. For example, they have 
suggested that older people have often been excluded from studies of CCBT in the 
past specifically because it has been assumed that they will find this treatment 
unacceptable. It could be argued that exploring the acceptability of BTB to older 
people is, therefore, an important first step to establish as, regardless as to whether the 
treatment is clinically and cost effective, it will not be viable if they do not accept this 
treatment.  
 
As described in the above sections, similar assumptions about finding treatments 
unacceptable were once falsely held regarding face-to-face psychological treatments 
with older people. In a small pilot study Elsegood and Powell (2008) found that the 
majority of the older people they surveyed would be willing to try CCBT, even if they 
had no previous experience of using computers (although no participant was actually 
required to go on and use the treatment) Their small study, therefore, begins to 
challenge the viewpoint that older people will not accept CCBT packages such as 
BTB. Whilst Elsegood and Powell (2008) provided some evidence in the form of a 
small survey that older people will accept BTB, the current study will be the first 
study to examine the acceptability of BTB to older people in actual practice (i.e. 
participants will be required to go on and use the treatment). The focus of the current 




regarded as one of the first steps in determining the utility of a treatment in actual 
practice i.e. regardless of how clinically and cost effective a treatment is found to be 
in a clinical trial, unless it is acceptable to patients it will not be viable for use in 
actual practice (Kaltenthaler et al, 2008).  
 
The current study will also meet a research recommendation described by 
Kaltenthaler et al (2006). These authors suggest that future research should explore 
patients’ preferences with regard to the uptake of BTB, as this is a key factor 
determining a treatments’ acceptability (Kaltenthaler et al, 2008). Kaltenthaler et al 
(2006) suggest that the acceptability of BTB should be explored with, for example, 
patient preference trials. In the current study, participants will be given a free choice 
about the treatment they receive as part of the study: BTB in addition to treatment as 
usual or just treatment as usual alone. A similar methodology has been used for 
exploring the acceptability of group versus face-to-face CBT for treating anxiety in 
adults of working age (Sharp et al, 2004). 
 
This design will allow an examination of the rate of uptake of this treatment when 
given a free choice. The study will also explore some of the participant characteristics 
that may influence the uptake of BTB amongst an older people population.  An 
alternative design, such as a RCT, would limit the possibility of these aims being 
explored. For example, patients who have a strong preference not to receive BTB may 
be unlikely to participate in a RCT. It would also be difficult to separate these 
individuals from those who would be reluctant to participate in any study, regardless 
of the treatment, which is a confounding factor when exploring the uptake rate of a 




which have examined the acceptability of BTB in terms of uptake, as it has not been 
possible to determine if patients declining to receive BTB did so as a result of not 
wanting to receive this treatment, or not wanting to participate in any study regardless 
of the treatment.  
 
The current study will also examine drop-out from BTB, which is another factor 
reflecting the acceptability of a treatment (Kaltenthaler et al, 2008). No study to date 
has explored the rate of drop-out from BTB amongst an older people population. The 
rates of drop-out will be discussed in terms of the findings from previous research that 
has examined BTB in adults of working age. 
 
The study will also meet one of the research recommendations outlined in the Health 
Technology Assessment on the use of BTB, which states that future research should 
be carried out by third-party researchers (i.e. independent of the developers of the 
packages: Kaltenthaler et al, 2006). No researcher in the current study had any 
connection with the development of BTB and there were no vested interests or 
conflicts of interest.  
 
1.6 AIMS & HYPOTHESES  
The primary aim of the study was to examine the acceptability and feasibility of the 
use of BTB for treating depression and anxiety with older people. A secondary aim 
was to begin to examine whether BTB is effective for treating depression and anxiety, 
with this population. With regard to this secondary aim the study should be 
considered primarily a pilot study, and not a controlled effectiveness trial, whereby 




terms of being able to draw conclusions about the effectiveness of BTB. This is 
discussed further below. Specific aims were examined with both descriptive statistics 
for explorative aims and inferential statistics for specific hypotheses that were tested.  
 
1.6.1 Primary aims and hypothesis  
Primary Aim 1: The first specific aim of the study is to examine the acceptability of 
BTB to older people, seeking treatment for depression and anxiety, indexed by the rate 
of uptake of this treatment. As an initial step the response rate of study participation 
(i.e. the percentage agreeing to take part in the study versus the percentage that 
declined) will be calculated. The uptake rate of BTB will subsequently be calculated 
by determining the percentage of participants who, when given a free choice, opted to 
receiving BTB plus treatment as usual versus the percentage who opted for treatment 
as usual alone.  This aim will be examined using descriptive statistics, which will be 
reported in comparison to the descriptive statistics for the uptake rates for BTB 
reported in previous research with other populations.    
 
Primary Aim 2: The second aim of the study was to examine the acceptability of 
BTB to older people in terms of rates of drop-out from treatment. This will be 
calculated by determining the percentage of participants who completed all eight 
sessions of BTB and the percentage who discontinued treatment prior to session eight. 
The mean number of sessions completed by all participants using BTB and the mean 
number of sessions completed by those who discontinued treatment will also be 
calculated. This aim will be examined using descriptive statistics, which will be 
reported in comparison to the descriptive statistics for the drop-out rates found in 




Primary Aim 3: The third aim of the study was to examine differences in the 
characteristics of participants who opted to receive BTB to those who declined this 
treatment. The purpose of this aim was to identify some of the characteristics that may 
influence whether or not older people accept this treatment, for example, their 
reported levels of confidence in using a computer. This third aim was examined using 
inferential statistics and the hypothesis was as follows: 
 
Hypothesis: Based on the research discussed in the introduction, relating to factors 
that have previously been found to influence older people’s use of computer 
technology, it was hypothesised that, in comparison to the TAU group, those in the 
BTB+TAU group would report significantly greater levels of confidence and 
experience in using a computer. The null hypothesis is that there will be no significant 
differences between the two groups in their reported confidence and experience in 
using a computer. In addition, other factors that will also be tested with inferential 
statistics include; examining whether the two treatment groups significantly differed 
on a range of demographic variables collected including; age, years of education, the 
number of reported co-morbid physical health problems, their gender, whether they 
were taking psychotropic medication, the duration of their current episode and their 
social deprivation category.  It was hypothesised that there would be no significant 
differences between the two groups on these variables, with the null hypothesis being 
that the two groups would significantly differ on one or more of these variables 
 
1.6.2 Secondary aims and hypotheses  
The secondary aim of the study was to begin to begin to examine how effective BTB 




a free choice about whether or not they wish to receive this treatment. Given the 
methodology used within the current study (i.e. patients being given a free choice 
about which treatment group they were part of, rather ran being randomly allocated to 
treatment) interpretation of the results in relation to this aim have to be treated with 
caution. The purpose of examining treatment outcome across the two groups was, 
therefore, done in the context of a pilot study primarily to explore the acceptability 
and feasibility of using BTB with older people. It should, therefore, not be interpreted 
in the context of a controlled treatment outcome study with the main purpose of 
determining the treatments effectiveness. 
 
Secondary hypothesis A: Based on previous research examining the effectiveness of 
BTB with other populations, it was hypothesised that when participants are given a 
free choice about whether they receive BTB (plus treatment as usual: BTB+TAU) or 
treatment as usual alone (TAU), those in the BTB+TAU group will show significantly 
greater reductions on measures of depression and anxiety than the TAU group, by the 
end of treatment and at a one month follow-up point. The null hypothesis is that there 
will be no significant differences between the two groups on measures of depression 
and anxiety following treatment. As described previously, interpretation of the results 
in relation to this hypothesis have to be treated with caution due to the design of the 
current study, which should be regarded as a pilot study focused on examining the 
acceptability and feasibility of BTB, rather than a controlled effectiveness study.  
 
Secondary Hypothesis B: A further hypothesis in relation to treatment outcome was 
that; following treatment and at one month follow-up, in comparison to the TAU 




meet criteria for clinically significant improvement on measures of depression and 
anxiety. The null hypothesis is that there will be no significant difference between the 
two groups by the end of treatment and at one month follow-up, in terms of those 
meeting criteria for clinically significant improvement. The same cautions, in terms of 
interpreting the results in relation to this hypothesis, as described for hypothesis 2 
























CHAPTER 2 –METHODOLOGY 
2.1 ETHICS  
Prior to the commencement of the study an application for ethical review by the local 
area NHS Research Ethics Committee (REC) was submitted through the Integrated 
Research Application System (IRAS). In addition, a submission was also made to the 
local area NHS Research and Development (R&D) Office for approval. Following 
attendance at the REC meeting the study was granted a favourable ethical opinion and 
was approved by the local area R&D office (see Appendices 1 & 2).   
 
2.2 DESIGN 
2.2.1 Study Design 
The study utilised a 2 (treatment group) x 3 (time), between groups design with time 
as a repeated measure. Participants were able to self-select, which of the two 
treatment groups they wished to be part of:  Beating the Blues (BTB) plus treatment as 
usual (BTB+TAU) or treatment as usual alone (TAU). Section 2.4 provides details of 
the treatments. Participants were not asked to indicate their choice until they had been 
given full details of the study and the BTB treatment and were aware of what the two 
treatment options would comprise. All participants were assessed using a range of 
outcome measures at pre-treatment (week 0), post-treatment (week 8) and one month 
follow-up (week 12) assessment points.  
 
2.2.2 Design Considerations 
When designing the study, there were different potential options available. A 
randomised control trial (RCT), in which participants are randomly allocated to 




treatment outcome research. One of the primary reasons for this is that confounding 
variables are equally distributed between the different groups, therefore reducing the 
impact of unsystematic variation. The use of randomisation means that the impact 
these confounds have upon the systematic variation, produced by the independent 
variable that is manipulated, is reduced and therefore a more sensitive measure of the 
experimental manipulation can be obtained (Field, 2009).  
 
One of the disadvantages of an RCT in terms of examining the acceptability and 
feasibility of a treatment is that it may not account for the impact of participants 
preferences have upon their participation and treatment outcome (Torgerson & Sibald, 
1998). For example, if participants have a strong preference to receive a particular 
treatment but are not randomised to this they may be ambivalent about the treatment 
they do receive. This has been referred to as “resentful demoralisation”, which has 
been suggested to have a negative effect upon factors such as participant’s adherence 
to the treatment (or control condition) to which they are allocated to (Janevic et al, 
2003). It has also been suggested that this can create a “negative placebo effect”, 
which may in-turn adversely affect participants overall treatment outcome (Janevic et 
al, 2003). In extreme circumstances individuals with preferences regarding which 
treatment they receive may refuse to participate at all in an RCT, and the absence of 
such participants reduces how much the results can be generalised to the wider 
population (Torgerson and Sibald 1998). 
 
In contrast, the opposite pattern can also occur whereby some participants may have 
such a strong preference for a treatment that they are allocated to that it may improve 




who do not have as strong a preference (Torgerson & Sibald, 1998). In studies of 
psychological treatment the impact of participant preference is particularly important, 
as it is often difficult to blind participants to the treatment they are receiving.  
 
Participant preference is particularly important in the context of the current study 
whereby it has been highlighted that relatively little is known about the acceptability 
of BTB, particularly with older people, where it has been assumed older people will 
prefer not to receive it and therefore will not accept it (Kaltenthaler et al, 2008). The 
use of an RCT at this stage, without initial research to inform its feasibility with older 
people, may limit the numbers of older people who agree to participate in such a 
study.  The acceptability of BTB to older people is therefore a key area in determining 
the treatments feasibility in practice for this population and an area that requires 
research. The uptake of a treatment is a particularly important factor when 
considering its acceptability (Kaltenthaler et al, 2008). Consequently, one of the aims 
of the study was to explore the acceptability of BTB in terms of the number of 
participants who wished to receive this treatment (the BTB+TAU group), compared 
to the number who were prepared to participate in the study but did not wish to 
receive BTB (the TAU group). As Kaltenthaler et al (2008) highlight, the refusal to 
take part in a trial exploring CCBT may suggest a reluctance to take part in any study, 
rather than a specific aversion to CCBT itself. Although asking patients about their 
reasons for non-participation in an RCT can also help answer this question, this 
creates an ethical issue as it is a specific requirement that potential participants do not 





The use of allowing participants to self-select which of the two treatment arms of the 
study they wished to be allocated to helps avoid some of the issues outlined above. 
This design was chosen for the current study and it allowed an examination of the 
number of participants who agreed to take part in the study (and the number who 
declined), and the number who subsequently accepted the BTB treatment compared to 
the number that did not.  A similar methodology has been used for exploring the 
acceptability of group versus face-to-face CBT for treating anxiety in adults of 
working age (Sharp et al, 2004). This methodology also arguably has a greater degree 
of external validity in comparison to an RCT as it is more reflective of what would 
typically occur in routine clinical practice (i.e. patients are generally provided with 
treatments they opt to receive). It should, however, be noted that due to the fact that 
participants were not randomly allocated to the treatment arms of the study this 
introduces a source of bias, which means the TAU condition may not fully control for 
the BTB+TAU group (i.e. as participants in the BTB+TAU may have a strong 
preference for BTB this may influence the treatment outcome). This in turn potentially 
means that conclusions regarding the direct efficacy of BTB should be treated with a 
degree of caution.  
 
The use of placing participants in the treatment group they have chosen is in line with 
the research recommendations made by Kaltenthaler et al (2006) in their Health 
Technology Assessment of CCBT. These authors state that the preference of patients 
should be built into the design of future studies in order to gain a better understanding 






2.3   PARTICIPANTS 
2.3.1 Participant Recruitment 
Individuals who were referred to an NHS regions older people secondary care mental 
health services for the treatment of depression and/or anxiety were recruited for the 
study.  A number of promotional and training sessions were completed with potential 
referrers prior to the start of the study.  An initial session involved the researcher 
attending a meeting with each of the 11 older people mental health service 
multidisciplinary teams (MDT’s) throughout the region from which participants were 
to be recruited. The purpose of this was to provide a presentation giving an overview 
of the study, the main aims of the study, the inclusion/exclusion criteria, information 
about the BTB treatment, and to answer any initial questions clinicians had.  
 
Following this, clinicians from each of the MDT’s were invited to attend an hour long 
training session on BTB. At these training sessions clinicians were provided with a 
standard demonstration video prepared by the developers of BTB, which gave an 
overview of the content of BTB and demonstrated what the treatment looks like when 
it is being used. They were also provided with written materials used routinely within 
the department, which gave details of the content of each session (see Appendix 3) 
 
Subsequent to the training session the researcher attended a further meeting with each 
of the MDT’s, to reinforce information regarding the details of the study and to 
provide clinicians with referrals packs so they could begin to refer patients to the 





Upon commencement of the study the researcher sent an update email to each 
clinician within the MDT’s approximately every 12 weeks to provide a brief summary 
of the number of referrals that had been received and to highlight that the study was 
still recruiting participants and new referrals would be welcomed. After 
approximately six months of the study commencing the researcher attended a further 
meeting with each of the MDT’s to provide a face-to-face update of the study, remind 
the clinicians of the aims of the study and the referral procedure and to encourage any 
patient meeting the inclusion/exclusion criteria to be approached about possible 
participation and if appropriate to refer them.  
 
2.3.2 Inclusion and Exclusion Criteria 
Individuals were included in the study if they met the following inclusion and 
exclusion criteria:  
 
Inclusion Criteria 
• Individuals aged 65 years and over (no upper age limit) seeking treatment 
from secondary care mental health services for depression and/or anxiety.  
• Individuals currently presenting with at least a mild level of depression and/or 
anxiety, as measured by the Hospital Anxiety and Depression Scale (HADS). 
Participants were included if they scored 8 or above on either the depression 
or anxiety sub-scale of the HADS.  
 
Exclusion Criteria 





• Individuals with a diagnosis of a dementia or who were currently being 
actively investigated for possible dementia (i.e. were awaiting a 
neuropsychological assessment or brain scan).  
• Individuals who were unable to read English or follow verbal instructions. 
• Individuals who were currently presenting with active suicidal ideation.  
• Individuals who were currently receiving a formalised psychological 
treatment, such as CBT, from an accredited therapist.  
• Individuals who had current difficulties with alcohol or drug dependence. 
 
2.4   TREATMENTS 
2.4.1 Beating the Blues (BTB) 
BTB was developed by Ultrasis UK Ltd and was first fully described and empirically 
evaluated in a pilot study by Proudfoot et al (2003a). BTB is described as an 
interactive, multimedia computer package which teaches practical skills, based on 
Cognitive Behaviour Therapy (CBT), to help manage symptoms of depression and 
anxiety (Proudfoot et al, 2003a). The package comprises eight sessions, completed on 
a weekly basis, with each session lasting approximately 45 – 60 minutes. Each session 
includes video clips, case vignettes, animations and interactive tasks designed to 
provide the user with the skills to understand and manage symptoms of depression 
and anxiety. A summary of the content of each of the sessions, which has been 
provided by the developers of BTB, is provided in Appendix 3. A brief overview of 























Figure 2.1 Overview of the Structure of BTB (adapted from Proudfoot et al, 2003a) 
 
A homework task is assigned to the participant at the end of each session, to be 
completed prior to the next session. This is designed to help facilitate users’ learning 
of the cognitive-behavioural techniques (Proudfoot et al, 2003a). These tasks include 
mood monitoring, activity scheduling, thought monitoring and challenging, as well as 
relaxation techniques. At the start of each session the participant provides a rating on 
a 0-8 point Likert scale in terms of how depressed and anxious they have felt over the 
last week and if they have had any feelings of suicide. This information is generated 
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into a progress report that is provided to the researcher. If the participant indicates 
they have felt suicidal an email alert is sent to the researcher, so the participant can be 
immediately contacted and provided with support if indicated.  
 
Proudfoot et al (2003a) also highlight that a number of features were incorporated 
into the program to enhance not only its direct therapeutic procedures but also to 
make it user-friendly for patients. The authors suggest that video vignettes of case 
study ‘patients’
6
, whose progress can be watched over the course of each of the 
sessions, were incorporated to increase participants interest and motivation in using 
the program. The authors also argue that the case studies serve a number of other 
therapeutic functions, such as presenting models of the cognitive-behavioural 
techniques which users can observe to help their own understanding and learning.  
The patients in the case studies are also designed to communicate hope for 
improvement to users, by allowing them to see that other people go through similar 
experiences and learn how to manage their difficulties. All these non-specific 
therapeutic factors are interwoven with the specific cognitive-behavioural strategies 
outlined in Figure 2.1 (Proudfoot et al, 2003a).  
 
2.4.2  Treatment as Usual 
Within the context of the current study no constraints were placed on what was 
provided as treatment as usual (TAU), with the exception that participants could not 
be receiving a formalised face-to-face psychological treatment from an accredited 
therapist (as per the inclusion/exclusion criteria). The clinician from the participant’s 
direct care team who referred the participant to the study was instructed to provide 
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whatever treatment felt necessary as part of the participant’s normal, routine care and 
treatment. This could include no direct treatment if this was what was deemed 
appropriate for the participant by their clinician.  
 
Prior to commencement of the study clinicians from the MDT’s were consulted 
regarding the types of treatment they would typically use with patients. Based on the 
information that was provided, treatment as usual was hypothesised to typically 
consist of: 1) outpatient assessment/review appointment with a psychiatrist; 2) 
psychotropic medication prescribed/reviewed; 3) social support/advice; 4) relaxation 
training; 5) attendance at day hospital; and 6) referral to another specialist (e.g. a 
clinical psychologist).  Information regarding the treatment as usual that was provided 
was gathered from clinicians from the referring MDT’s at the end of the study. 
Participants were also asked about the treatment as usual they received, including 
whether they continued to be prescribed or had been commenced on psychotropic 
medication at the end of the study. The adherence to the exclusion criteria, with 
regard to point six listed above, was evaluated through monitoring of incoming 
referrals to the older people clinical psychology services throughout the region 
(adherence to this exclusion criteria was high in the study: see section 3.4.2, p 112).  
 
2.5   MATERIALS 
2.5.1 Referral Pack 
Referral packs containing all the relevant information (e.g. details of the study and the 
inclusion/exclusion criteria) and the forms required to make referrals were provided to 





2.5.1.1 Participant Information Sheet 
All potential participants who were approached about their possible participation in 
the study were provided with a Participant Information Sheet (see Appendix 4). This 
provided information about the study, what the aims were, and what participation 
would entail. It also contained contact details for the researcher and an independent 
advisor should they have any initial questions.  
 
2.5.1.2 Consent Form 1 
This form was completed by all the potential participants who agreed to be referred 
about their possible participation in the study (see appendix 5). It was made clear in 
the Participant Information Sheet and by the clinician from the potential participant’s 
MDT that completion of this form did not mean they were consenting to take part in 
the study. They were advised they were only consenting to be contacted by the 
researcher to arrange an initial recruitment meeting in which they would have 
information on the study clarified before deciding if they wished to participate. The 
consent form contained a section to provide the contact details for the potential 
participant and the referrer.  
 
2.5.1.3 The Hospital Anxiety and Depression Scale (HADS) 
To confirm eligibility to take part in the study the HADS was used to screen for the 
presence of symptoms of depression and anxiety.  This self-report measure has been 
used extensively for this purpose and is reported to have been used in 747 published 
studies and has been found to be a valid and reliable tool for identifying the presence 
and severity of depression and anxiety (Bjelland, 2002). The HADS is also 




self-report measures for screening for the presence of depression and anxiety in older 
people above the age of 65 years (BPS, 2004).  
 
The HADS comprises two distinct scales for depression and anxiety. Each scale has 
seven questions relating to different symptoms, which the patient answers by 
choosing an option between 0 and 3, based on the severity/intensity/frequency with 
which they have experienced the symptoms. The total score possible for each scale is 
21. A score of 0 to 7 on either of the scales is rated as being within the "normal" 
range. Patients scoring 8 to 10 on either scale are rated as having "mild" difficulties, 
those scoring 11 to 15 are rated as having "moderate" difficulties and those scoring 16 
to 21 are rated as having "severe" difficulties. Patients scoring 8 or above on either of 
the two HADS scales were eligible for participation in the present study.  
 
2.5.1.4 Recruitment Questionnaire  
This consisted of three questions: 1) the potential participant’s date of birth; 2) the 
first four digits of their postcode; and 3) whether they agreed to be referred for an 
initial recruitment meeting with the researcher (see Appendix 6). This form was 
completed by the clinicians from potential participant’s direct care team. It allowed 
the monitoring of the total number of potential participants approached about the 
study and how many subsequently agreed/declined to be referred for an initial 
recruitment meeting.  
 
2.5.2 Outcome Measures 
Participants who agreed to take part in the study in both the BTB+TAU group and the 




symptoms of depression and anxiety prior to treatment, after the completion of 
treatment and at one month follow-up. They also completed a consent form for taking 
part in the study (see appendix 7). The following measures were used: 
 
2.5.2.1 The Clinical Outcomes in Routine Evaluation (CORE-34).  
The CORE-34 is a self-report measure that was developed for use throughout the UK 
to be used in routine practice for evaluating outcomes for psychological therapies (see 
Appendix 8). It consists of thirty-four questions that are rated on a 0 – 4 point Likert 
scale. The results of the CORE-34 are separated into four domains relating to 
wellbeing, problems/symptoms, life functioning and risk. A total composite domain 
score can also be obtained. The CORE-34 has been reported to be a valid and reliable 
assessment for measuring outcomes from psychological treatment (Evans et al, 2000). 
For example, Evans et al (2000) reported Cronbach’s alpha coefficients of .94 for the 
total domain and Cronbach alpha coefficients ranging from .79 to .90 for the four sub-
domains, highlighting the internal consistency of the measure. In addition, these 
authors reported test-retest reliability coefficients ranging from .87 to .90 for each of 
the domains. Evans et al (2000) suggest that the CORE demonstrates good convergent 
validity of the CORE with strong correlations between it and a number of other 
measures of psychopathology e.g. BDI (.85), BAI (.65) and SCL-90-R (.88)   
Furthermore, Evans et al (2000) found significant differences between a clinical and 
non-clinical sample of participants on their CORE scores, providing evidence that it 
was a valid and reliable measure for differentiating these two samples. Since 2001 the 
CORE has been used in 450 services in the UK and data have been collated for 300 
000 patients. The CORE is recommended by the BPS (BPS, 2004) as an assessment 




BTB (e.g. Learmonth & Rai, 2008), which have demonstrated an improvement in 
scores over the course of treatment.  
 
2.5.2.2 The Geriatric Depression Scale (GDS) 
The GDS is a self-report measure designed specifically for use with older people (see 
Appendix 9). It contains 30 questions relating to symptoms of depression, to which 
the patient answers “yes” or “no”, depending on whether or not the symptom has been 
present over the previous week. The questionnaire is scored out of a possible 30, with 
a score of 0 – 9 being classified as in the "normal" range, a score of 10 – 19 being 
classified as "mild depression" and a score of 20 – 30 being classified as "severe 
depression". The GDS has been shown to be a valid and reliable measure for detecting 
the presence of and severity of depression in people 65 years and above (Yesavage et 
al, 1983). For example, Yesavage et al, (1983) found Cronbach alpha coefficients of 
.94 and split-half reliability coefficients of .94, demonstrating the internal consistency 
of the GDS. The authors also found test-retest reliability coefficients of .85 for the 
GDS. Yesavage et al (1983) also suggest the GDS is a valid and reliable measure for 
differentiating between clinical and non-clinical samples as they found significant 
differences between participants scores on the GDS from each of these two groups. 
Lastly the authors found significant correlations between participants scores on the 
GDS and other measures of depression such as the Zung Self Rated Depression Scale 
(.84) and the Hamilton Rating of Depression Scale (.83). The GDS is reported to be 
one of the most widely used assessments for detecting and rating the severity of 
depression with older people in a range of different settings (Montorio & Izal, 1996). 
A review by the BPS (2004) of all the assessment tools routinely used with older 




can be used before and after treatment to assess older people’s progress after 
receiving treatment.  
 
2.5.2.3 The Geriatric Anxiety Inventory (GAI) 
The Geriatric Anxiety Inventory is a self-report measure designed specifically for use 
with people over the age of 65 years (see Appendix 10). It contains 20 questions 
relating to symptoms of anxiety, to which the patient answers “yes” or “no”, 
depending on whether or not the symptom has been present over the previous week. 
The questionnaire is scored out of 20, with a score of 0 – 8 being classified as in the 
"normal" range and a score of 8 and above being indicative of the presence of an 
anxiety disorder. The GAI has been shown to be a valid and reliable measure for 
detecting the presence of anxiety in older people in a range of settings (Pachana et al, 
2007). For example, Pachana et al (2007) found Cronbach alpha coefficients of .91 
highlighting the internal consistency of the GAI. The authors also found test-retest 
reliability coefficients of .91. Furthermore, they found that the GAI was significantly 
correlated with other measures of anxiety, such as the Beck Anxiety Inventory (.63), 
State Trait Anxiety Inventory (.80) and the Penn State Worry Questionnaire (.70). 
Lastly, the GAI was found to differentiate between clinical participants experiencing 
anxiety and non-clinical control participants, with significant differences between the 
two groups in their scores on the GAI.   It has been recommended as an appropriate 
measure for assessing the severity of anxiety in older people and can be used to 







2.5.2.4 Demographics Questionnaire 
A demographics questionnaire was completed by all participants taking part in the 
study (see Appendix 11). This included a section relating to participants’ experience 
and confidence in using a computer.  
 
2.6  PROCEDURE. 
The procedure for the study is illustrated schematically in Figure 2.2 
 
2.6.1 Initial Approach to Potential Participants 
Prior to the commencement of the study (and throughout the running of the study) the 
researcher liaised closely with clinicians from the MDT’s regarding details of the 
study, including, for example, the inclusion/exclusion criteria. Potential participants 
were known to the clinicians from the MDTs, who were able to assess whether they 
met the inclusion/exclusion criteria and had access to their medical records to confirm 
any details.  
 
Potential participants meeting the inclusion/exclusion criteria were approached by a 
clinician from the MDT at a routine appointment about their interest in finding out 
about the study. These clinicians had been provided with referral packs described in 
the Materials section above. Potential participants were offered the Participant 
Information Sheet by their clinician and were supported in reading and understanding 
this. The contact details of the Chief Investigator (the researcher) and an Independent 































Caseloads screened by members of direct clinical care teams for potential participants 
meeting clinical inclusion/exclusion criteria 
Potential participants meeting inclusion/exclusion criteria are approached by member of 
direct clinical team at routine appointments.  
• Participant Information Sheet provided to potential participants  
• Potential participants expressing an interest, complete Consent form 1 
• HADS administered by direct clinical care team to confirm eligibility  
• Recruitment Questionnaire completed by direct clinical care team for all potential 
participants approached   
Potential participant 
declines to take part 
 
Participant doesn’t meet 
HADS inclusion criteria 
 
(Continue TAU) 
Potential participant attends information session with member of the research team.  
• Beating the Blues demonstration provided if requested. 
• Information about the study clarified and questions answered 
• Consent form 2 completed by those wishing to participate 
• Demographics Questionnaire completed 
 
Potential participants 
decline further participation  
 
(Continue TAU) 
Beating the Blues + treatment as usual (TAU + BTB) 
 
Participants continue to receive treatment as usual plus 8 
sessions, on a weekly basis, of Beating the Blues 
treatment as usual (TAU) 
Participants continue to receive treatment as usual. 
This could include 1) outpatient assessment/review 
appointment with a psychiatrist; 2) psychotropic 
medication prescribed/reviewed; 3) social 
support/advice; 4) relaxation training; 5) attendance at 
day hospital; and 6) referral to another specialist 
 
Pre-treatment assessment - GDS & GAI & CORE 
 
 
Week 0 – BTB session 1 
 
Week 1 – BTB session 2 
 
Week 2 – BTB session 3 
 
Week 3 – BTB session 4 
 
Week 4 – BTB session 5 
 
Week 6 - BTB session 6 
 
Week 6 - BTB session 7 
 
Week 7 – BTB session 8  
 
Week 8 – post treatment assessment 
 




Pre-treatment assessment - GDS & GAI & CORE 
 
 
















Week 8 – post treatment assessment 
 




Week 12 – 1 month follow-up 
 






Week 12 – 1 month follow-up 
 







Potential participants who expressed an initial interest in taking part in the study were 
asked to sign Consent Form 1 to allow their contact details to be provided to the 
researcher. They were also asked to complete the HADS questionnaire to confirm 
whether or not they met the inclusion criteria.  It was made clear in the Participant 
Information Sheet and by the clinician from their direct care team that they could take 
more time to consider the information further before deciding if they wished to have 
their contact details provided to the researcher. It was also emphasised that by signing 
Consent Form 1 they were not agreeing to participate in the study, but just to be 
contacted to arrange a meeting with the researcher. 
 
Those potential participants who did not wish to participate or who scored below the 
inclusion criteria cut off on both the HADS scales were excluded from the study and 
continued to receive their treatment as usual (i.e. whatever treatment they normally 
receive as part of their normal routine care).  
 
Clinicians from the direct care team completed the Recruitment Questionnaire for all 
potential participants approached to take part (including those who did not wish to be 
referred), which was returned to the researcher in stamped address envelopes. This 
allowed an examination of the number of patients initially approached to take part in 
the study and the number agreeing/declining to be referred.  
 
2.6.2 Initial Recruitment Meeting 
For participants who agreed to be referred, an initial recruitment meeting was 
arranged with the researcher. At this meeting information relating to what was 




opportunity to have any questions answered. Potential participants were also offered 
the opportunity to view a standard video demonstration of BTB. Potential participants 
were then asked whether they wished to take part it the study. It was also made clear 
that they could take more time to consider their decision if required.  
 
2.6.3 Allocation to Group, Assessment & Treatment  
Participants were allocated to the treatment as usual group (TAU) or the BTB plus 
treatment as usual group (BTB+TAU), based their choice.  
 
2.6.3.1 Treatment as Usual (TAU) 
Throughout their participation in the study all participants in this group continued 
with their treatment as usual (i.e. whatever treatment they had already been receiving 
as part of their normal, routine care and treatment, as detailed above in section 2.4.2, 
(p 82). At week 0 participants attended a session with the researcher to complete the 
GDS, the GAI and CORE-34 pre-treatment measures. They were again contacted at 
week eight and week by the researcher to complete the post-treatment and one month 
follow-up measures. In the interim period between the initial session with the 
researcher and the subsequent follow-up points with the researcher, participants 
continued to receive treatment as usual, which, based on information gathered from 
clinicians prior to the study was hypothesised to include: 1) outpatient 
assessment/review appointment with a psychiatrist; 2) psychotropic medication 
prescribed/reviewed; 3) social support/advice; 4) relaxation training; 5) attendance at 
day hospital; and 6) referral to another specialist. At the end of the study the clinician 




number of treatment as usual sessions that had been provided and the primary content 
of treatment as usual.  
 
2.6.3.2 BTB plus Treatment as Usual (BTB + TAU) 
Participants in this group followed the same procedure as to what is detailed in the 
TAU section above (2.6.3.1). In addition, at week 0 participants in the BTB+TAU 
group completed their first BTB session. Participants were given the option of 
completing their BTB sessions at home, if they had access to a computer with a 
broadband connection. Alternatively, participants were able to attend one of several 
sites in the community that were already established for the use of BTB by patients 
from the NHS region where the study was being conducted. These sites included a 
primary care Psychological Therapies Service Department and local pharmacies and 
libraries. The researcher was present throughout the whole of session one of BTB to 
support the participant in the technical use of the program. No specific guidance was 
provided regarding answering particular questions on the computer program or 
completing specific tasks set by the program.   
 
Participants subsequently completed the remaining seven sessions independently on a 
weekly basis. If participants were completing the sessions at home they were asked to 
contact a member of the research team each week by telephone to ‘book’ when they 
were planning to do each of their sessions. They also had the contact numbers of the 
researcher and who they could contact if they had any specific problems with using 
the program (e.g. if they forgot their password, etc). Participants completing their 
sessions in the community booked each of their sessions with a member of staff at 




could provide any technical assistance to participants if this was required. No help or 
support was provided regarding completing the actual content of the BTB sessions. If 
a participant did not attend an appointment or did not complete a home session when 
they had booked it they were contacted by telephone by the researcher to ascertain if 
they wished to discontinue BTB, or if they had forgotten. Those who had simply 
forgotten were encouraged to book and complete the session at a time later in the 
week.  
 
2.7 POWER CALCULATION & SAMPLE SIZE 
G*Power 3 (Faul et al, 2007) was used prior to the start of the study to estimate the 
sample size required to detect a statistically significant differences between the two 
groups. The purpose of this was to avoid making a Type II error and incorrectly 
accepting the null hypothesis that there are no significant differences between the two 
groups by the end of treatment, as a result of too small a sample size. Previous 
research comparing Beating the Blues plus treatment as usual to treatment as usual 
alone has found effect sizes of 0.63 (Proudfoot et al 2004 (analysis combined with 
Proudfoot et al, 2003b)) and 0.85 (Grime, 2004). Using the more conservative effect 
size of 0.63, for the current study a sample size of 64 (32 per group) was calculated to 
be required to detect a significant difference between the groups at .80 power and 









CHAPTER 3 – RESULTS 
In this chapter the methods used to examine the obtained data prior to conducting the 
statistical analysis for the primary aims and hypothesis of the study are initially 
described. An analysis of the results in terms of the primary aims and hypothesis of 
the study is presented in sequence in section 3.2. This is followed by an analysis of 
the secondary aims and hypotheses of the study in section 3.3. 
 
3.1 DATA ANALYSIS  
3.1.1 Analysis of Assumptions 
Prior to conducting the statistical analyses it is necessary to determine if the obtained 
data violated/satisfied the assumptions of parametric statistical analysis. The data 
were therefore first examined to check the normality of the distributions. Field (2009) 
suggests that the values of skew and kurtosis, which determine the normality of a 
distribution, can be divided by their respective standard error (SE) to produce a z-
score. These z-scores can then be compared to the z-scores produced by a normal 
distribution to determine if the obtained data are normally distributed (i.e. it can be 
determined whether the obtained z-scores significantly differ to those produced by a 
normal distribution). Field (2009) states that obtained z-scores greater than 1.96 are 
significant at p < .05, z-scores greater than 2.58 are significant at p < .01 and z-scores 
greater than 3.29 are significant at p < .001, and therefore violate the assumptions of 
normality.  
 
In addition, the Kolmogorov-Smirnov test can be used to determine whether the 
distributions of the obtained data are significantly different from a normally 




data set (Field, 2009). If the Kolmogorov-Smirnov test is significant (i.e. p < .05) this 
indicates the obtained data significantly differs from a normal distribution and 
violates the assumption of normality. Field (2009) also highlights that if the research 
questions of a study involve exploring differences between two or more groups then 
the normality of the distributions within each of these groups is more important than 
the normality of sample as a whole (i.e. both groups combined). When conducting the 
analysis of normality the output was therefore split between the two groups in the 
current study. The results are summarised in Table 3.1 below, which shows the 
obtained z-scores and results from the Kolmororov-Smirnov (KS) tests, with 
significant findings highlighted in red.  
 
Table 3.1 Examination of normality of baseline outcome and demographic variables 





















 TAU 75.55 (6.27) 75 .41 (.51) 0.80 -.42 (.99) -0.42 .15 .20 
Education BTB+TAU 11.70 (2.56) 10 .97 (.41) 2.37 -.43 (.80) -0.53 .32 <.000 
 TAU 10.25 (1.88) 10 2.46 (.52) 4.81 5.66 (.99) 5.70 .40 <.000 
Health BTB+TAU 2.45 (1.46) 2 .160 (.41) 0.39 -.63 (.80) -0.78 .14 .088 
 TAU 2.45 (1.50) 2 .36 (.51) 0.71 .25 (.99) 0.24 .17 .143 
Experience BTB+TAU 4.67 (2.70) 5 -.40 (.41) -0.98 -.62 (.80) -0.77 .13 .172 
 TAU 1.40 (2.83) 0 1.93 (.51) 3.77 2.46 (.99) 2.47 .44 <.000 
Confidence BTB+TAU 5.33 (2.70) 6 -.57 (.41) -1.39 -.45 (.80) -0.56 .15 .065 





















 TAU 20.95 (6.03) 23 -.66 (.51) -1.28 -.52 (.99) -0.52 .19 .171 
GAI BTB+TAU 13.48 (6.01) 15 -.65 (.41) -1.58 -.82 (.80) -1.03 .15 .056 
 TAU 14.15 (5.537) 16.5 -.51 (.51) -0.99 -1.21 (.99) -1.27 .11 .250 
CORETotal BTB+TAU 52.30 (18.14) 49 .09 (.41) 0.21 -.39 (.80) -0.48 .13 .200 
 TAU 49.50 (16.89) 48 -.17 (.51) -0.33 -.39 (.99) -0.38 .10 .200 
CORE-W BTB+TAU 8.76 (3.08) 8 .40 (.41) 0.97 -.12 (.80) 0.14 .14 .087 
 TAU 8.10 (3.24) 7.5 .10 (.51) 0.28 -.180 (.99) -0.17 .13 .200 
CORE-R BTB+TAU 1.79 (2.42) 1 1.63 (.41) 3.98 2.78 (.80) 3.48 .26 <.000 
 TAU 0.60 (1.04) 0 1.54 (.51) 3.01 1.04 (.99) 1.04 .42 <.000 
CORE-F BTB+TAU 17.12 (6.99) 16 .57 (.41) 1.40 .86 (.80) 1.07 .15 .068 
 TAU 17.05 (6.85) 16 .91 (.51) 1.77 1.86 (.99) 1.87 .13 .200 
CORE-P BTB+TAU 24.39 (9.41) 24 -.08 (.41) -0.20 -.60 (.80) -0.75 .73 .200 




As can be seen from Table 3.1, three demographic variables violated the assumptions 
of normality (number of years of education in both treatment groups and confidence 
and experience in using a computer in the TAU group). As these variables were to 
undergo statistical analysis to explore differences between the two treatment groups, 
non-parametric tests were used for these variables (the Mann-Whitney U test).  
 
As can also be seen from Table 3.1, in terms of the outcome measures that were used 
in relation to the secondary aims of the study, the only variable that violated the 
assumptions of normality was the risk sub-scale of the CORE-34 (CORE-R).  Given 
the nature of the questions that make up this sub-scale and the exclusion criteria for 
the study, whereby individuals who were expressing active suicidal ideation were 
excluded, it is perhaps unavoidable that the data skewed towards low responses on 
this sub-scale. As this variable violated the assumption of normality, and as it was not 




Means and standard deviations (SD) were calculated for all continuous variables and 
numbers and percentages were calculated for categorical data. Comparisons between 
the two treatment groups in terms of demographic variables, pre-treatment scores on 
outcome measures and study completion/drop-out rates were made with independent 
t-tests (or Mann-Whitney U tests for variables where the data violated assumptions of 
normality), for continuous data and Chi-square tests for categorical data. The statistics 





3.2 DESCRIPTION & ANALYSIS OF FINAL STUDY SAMPLE 
3.2.1 Rates of Recruitment and Uptake of Treatment – Primary Aim 1 
Figure 3.1 shows diagrammatically the flow of patients through the study from the 
initial approach regarding their possible participation to the completion of one month 
follow-up assessment measures. This provides an overview of the rate of uptake and 
drop-out from the respective treatment conditions.   
 
3.2.1.1 Overall Recruitment to Study 
A total of 77 patients were approached about their possible participation in the study. 
Fifty-eight (75.3 per cent) subsequently agreed to be referred to the study, whilst 19 
(24.7 per cent) declined. All 58 individuals who were referred subsequently agreed to 
participate in the study and met the inclusion/exclusion criteria. An analysis of 
differences between patients who agreed to participate and those who declined (i.e. 
who did not wish to be referred to the study) in terms of age and Deprivation 
Category (DepCat) are provided in Table 3.2.   
 
As can be seen from Table 3.2, those who declined to be referred to the study (non-
participants) were older (mean (SD) = 78.32 (7.17)) than those who agreed to 
participate (mean (SD) = 73.43 (5.88)) and this difference was statistically significant 
(t (75) = 2.97, p < .01). As the mean age of participants was 73.08 years this indicates 
those in the ‘oldest-old’ age category were under-represented in the current study, 
despite no upper age limit being imposed. This is reflected in other studies that have 






Table 3.2 also shows that there was no significant difference between participants and 
non-participants in terms of DepCat classification (χ
2 
(2) = .398, p = .53 ns). The 
majority of both participants and non-participants were in the I-III classification, 
which indicates that most of the individuals approached about participation came 
from less socially deprived areas.  
 
Table 3.2 Characteristics of participants vs. non-participants 
Variable Study Participants 
N = 58 
Non-participants 




Mean SD Mean SD t d.f. p 
Age 
 
73.43 5.88 78.32 7.17 2.97 75 < .01 
        
 
 
N % N % χ
2
 d.f. p 
DepCat        
I - III 35 60.3 13 68.4    
IV-VII 23 39.7 6 31.6    
     .398 2 .53 (ns) 
 
 
3.2.1.2 Allocation to Treatment Group – Rates of Uptake of BTB 
Of the 58 participants recruited to the study 38 (65.5 per cent) indicated a preference 
to receive BTB and were allocated to the BTB+TAU group. The remaining 20 (34.5 
per cent) participants indicated that they did not wish to receive BTB and were 
allocated to the TAU group. A description of the demographic characteristics of the 
two groups of participants is provided in Table 3.3, including an analysis of 
differences between the two groups. After group allocation, five participants in the 
BTB+TAU group did not attend for their first BTB session and did not complete any 
of the pre-treatment assessment measures. Two of these participants reported 
significant physical health problems diagnosed after they were allocated to treatment, 




was unknowingly also referred for individual face-to-face psychological therapy by a 
different referrer and this participant indicated a preference to begin this rather than 
continue in the study. Two participants did not provide any reasons for dropping-out 
of the study prior to the first BTB session. These five participants were excluded from 
subsequent treatment outcome analyses, as they had not completed any pre-treatment 
assessment measures, had not completed any BTB sessions and had indicated they did 
not wish to continue to participate in the study. From the total number of participants 
recruited to the study (58), the total number who opted for BTB and then started the 
first session was 33, resulting in an uptake rate of 56.9 per cent. 
 
3.2.2 Analysis of Differences in Demographic Characteristics – Primary Aim 2 
As can be seen from Table 3.3 there were significant differences between the two 
treatment groups on the following variables; age (t (51) = 2.70, p < .01), years of 
education (Mann-Whitney U = 198, p < .01), self reported confidence in using a 
computer (Mann-Whitney U = 101, p < .001), self reported experience with using a 
computer (Mann-Whitney U = 135, p < .001) and whether or not they had access to 
the internet at home (χ2 (1) = 7.92, p < .01). Analysis of the means of the two groups 
on each of these variables highlights that in comparison to the TAU group the 
BTB+TAU group were younger, had more years of education, were more likely to 
have access to the internet at home and reported having more experience and 










Table 3.3 Demographic characteristics of study participants 
Variable BTB+TAU 
N = 33 
TAU 




Mean SD Mean SD  
Age 
 
71.58 4.43 75.55 6.27 t (51) = 2.70, p < .01 
Years of Education 
 
11.70 2.56 10.25 1.88 Mann-Whitney U = 198, p < .01 
Number of Co-morbid  
Physical Illnesses  
 
2.45 1.46 2.45 1.50 t (51) = .01, p = .991 (ns) 
Self Reported Confidence  
Using Computers (0-9 scale) 
 
5.33 2.70 1.30 2.65 Mann-Whitney U = 101, p < .001 
Self Reported Experience  
Using Computers (0-9 scale) 
 
4.67 2.67 1.40 2.83 Mann-Whitney U = 135, p < .001 
 
 
N % N % χ
2
 d.f. p 
Gender:        
Male 8 24.2 6 30.0    
Female 25 75.8 14 70.0    
     .21 1 .645 (ns) 
Access to Internet at  
Home: 
       
Yes 23 69.7 6 30.0    
No 10 30.3 14 70.0    
     7.92 1 < .01 
Currently Taking  
Psychotropic Medication: 
       
Yes 26 78.8 19 95    
No 7 21.2 1 5    
     2.55 1 .234 (ns)* 
Previous Psychiatric 
History: 
       
Yes 23 69.7 15 75.0    
No 10 30.3 5 25.0    
     .17 1 .678 (ns) 
Duration of Current 
Treatment Episode:  
       
1-3 Months 4 12.1 3 15    
4-12 Months 16 48.5 8 40    
>12 Months 13 39.4 9 45    
     .49 1 .795 (ns)* 
Deprivation Category 
(DepCat): 
       
I -III 20 60.6 11 55.0    
IV-VII 13 39.4 9 45.0    
     .16 1 .688 (ns) 





In contrast, the groups did not significantly differ in terms of the number of co-morbid 
physical health problems they reported (t (51) = .01, p = .991 (ns)) and whether they 
were taking psychotropic medication at the start of their participation in the study (χ
2 
(1) = 2.55, p = .234 (ns)). Nor did they significantly differ regarding whether they had 
a previous psychiatric history, for which they had received treatment, prior to their 
current episode of treatment (χ
2 
(1) = .17, p = .678 (ns)). There were also no 
significant differences between the two groups regarding the duration of their current 
episode of treatment (χ
2 
(1) = .49, p = .795 (ns)) and their DepCat classification (χ
2 
(1) = .16, p = .688 (ns). In addition, the groups did not significantly differ in terms of 
the number of males and females in each group (χ
2 
(1) = .21, p = .645 (ns). Overall, 
however, there was a higher proportion of females than males in both groups.  
However, this imbalance is reflective of the overall population of the region from 
which participants were recruited, whereby the population of females over the age of 
65 years is 66 per cent compared 34 per cent who are male (NHS, 2007).  
 
3.2.3 Study Attrition Rates – Primary Aim 3 
3.2.3.1 BTB+TAU Group 
A total of nine (27.3 per cent) participants who began BTB subsequently discontinued 
the BTB treatment (treatment discontinuers) prior to the final session, whilst 24 (72.7 
per cent) completed the full course of eight sessions. Of the nine participants who 
discontinued BTB, seven completed post-treatment assessment measures to assess 
their treatment outcome. The remaining two participants (study drop-outs) who did 
not complete post-treatment assessment measures had these values replaced using the 





A total of 28 (84.8 per cent) participants in the BTB+TAU group completed the one 
month follow-up assessment measures. The five participants (which included the two 
participants who did not complete the post treatment assessment measures) who did 
not complete the one month follow-up assessment measures had these values replaced 
using LOCF to enable intention-to-treat analysis. A summary of participants reasons 
for discontinuing BTB are summarised in Table 3.4. Although participants were not 
required to give a reason for dropping out, many spontaneously gave a reason.  
 
Table 3.4 Reasons provided for discontinuing BTB 
Reason Provided by Participants N 
BTB session when 
discontinued 
Found BTB unhelpful 1 4 
Found computer hardware too difficult to use 1 1 
Offered opportunity of face-to-face counselling  1 5 
Physical health significantly deteriorated    2  1 & 4 
Personal computer malfunction 1 6 
Felt better and did not wish to continue 1 4 
Difficulties concentrating due to anxiety 1 4 
No reason provided 1 1 
Total  9 - 
 
3.2.3.2 TAU Group 
Of the 20 participants who were allocated to TAU and who completed the pre-
treatment assessment measures, three (15 per cent) subsequently dropped-out of the 
study by the post treatment assessment point (i.e. they declined to complete the post-
treatment outcome measures). An additional two patients subsequently dropped-out of 
the study by the one month follow-up point. It was not possible to obtain detailed 
information about the reasons for dropping-out of the study for this group due to the 
nature of their participation, which involved completing a series of questionnaires (as 
well as continuing with treatment as usual). When they were contacted, the 
participants who dropped out from this group at the post-treatment and one-month 





3.2.3.3 Differences in Study Attrition Rates by Treatment Group 
Table 3.5 shows an analysis of differences between the two treatment groups in terms 
of those who remained enrolled in the study and completed outcome measures 
(including those who discontinued BTB but completed assessment questionnaires) and 
those who dropped out of the study. As can be seen in Table 3.5, there was no 
significant difference between the BTB+TAU group and the TAU group in terms of 
the number of participants dropping out of the study by the post-treatment or one 
month follow-up assessment points (post treatment assessment point, χ
2 
(1) = 2.41, p 
= 135 ns; one month follow up assessment point, χ
2   
(1) = 1.67, p = 173 ns).  
 
Table 3.5 Analysis of outcome measure completion and study drop-out rates 
Variable 
BTB+TAU 
N = 33 
TAU 
N = 20 Summary Statistics 
 
 
N % N % χ2 d.f. p 
Post Treatment        
Outcome Measure Completers   31 93.9 16 80.0    
Study Drop-outs 2 6.1 4 20.0    
     2.41 1 .135* (ns) 
One Month Follow-up        
Outcome Measure Completers 28 84.8 14 70    
Study Drop-outs  5 15.2 6 30    
     1.67 1 .173 (ns) 
* Fisher’s exact test statistic was used due to expected frequencies < 5 in the sample 
 
A further analysis of differences in the drop-out rate between the two groups, which 
placed all BTB treatment discontinuers within the drop-out category, is illustrated in 
Table 3.6. This highlights that a higher percentage of individuals in the BTB+TAU 
discontinued BTB, in comparison to the percentage that dropped out the study from 




cent drop out in the TAU group). This difference was not, however, statistically 
significant χ
2   
(1) = .356, p = .744 ns. 
 
Table 3.6 Analysis of study completers and study drop-out rates 
Variable 
BTB+TAU 
N = 33 
TAU 
N = 20 Summary Statistics 
 
 
N % N % χ2 d.f. p 
        
Study Completers   24 72.7 16 80.0    
BTB discontinuers & Study Dropouts 9 27.3 4 20.0    
     .356 1 .744* (ns) 
* Fisher’s exact test statistic was used due to expected frequencies < 5 in the sample 
 
 
3.3 SECONDARY AIM – Examination of treatment outcome 
3.3.1 Statistics & Assumptions 
Assumptions of parametric statistics relevant to the analysis being conducted for the 
secondary aim are homogeneity of variance and sphericity. An examination of the 
homogeneity of variance between the BTB+TAU group and the TAU group was 
therefore conducted using a series of Levene’s test. For all the outcome measures 
undergoing this analysis, with the exception of the risk sub-scale of the CORE-34, 
Levene’s tests were non-significant indicating that the data did not violate this 
assumption. When conducting repeated measures ANOVAs, sphericity was examined 
using Mauchley’s test and corrections were made if this was significant. When 
sphericity estimates are .75 and less, the Greenhouse-Geisser correction is used, when 
they are greater than .75 then the Huynh-Feldt correction should be applied (Field, 
2009). It is stated in the relevant sections below when these corrections were used 





Outcome from treatment was analysed using a series of 3 (Time) x 2 (Treatment 
Group) ANOVAs with time as the repeated measure. All analyses were intention-to-
treat. Post treatment and one month follow-up effect sizes were calculated between 
the two groups using Cohen’s d (Cohen, 1988)
7
.  An examination of the clinical 
significance of the results was also made using criteria set out by Jacobson and Truax 
(1991), which is described in greater detail in section 3.4.2.  
 
3.3.2 Missing Data & Intention-to-Treat Analysis 
Participants who discontinued treatment (e.g. if they stopped BTB before the last 
session) prior to the post-treatment assessment point were offered the opportunity to 
complete the post-treatment and one month follow-up outcome measures. Participants 
who agreed to complete these outcome measures were referred to as “treatment 
discontinuers”. Participants who discontinued treatment and then subsequently 
declined to complete post-treatment and one month follow-up outcome measures were 
referred to as “study drop-outs”.  
 
An analysis of the rates of discontinuers and drop-outs between the two treatment 
groups is described in more detail in section 3.2. An Intention-to-Treat (ITT) analysis 
was used when conducting all the statistical analyses exploring the outcome from the 
two treatment conditions. This is a more conservative approach, whereby all the 
individuals who begin treatment, including those who subsequently discontinue or 
drop-out, are entered into the data analysis. An alternative method of only including 
those who complete the full course of treatment may bias the results in favour of a 
                                                 
7
 Cohen’s d is derived from the following formula:  Mean (TAU) – Mean (BTB+TAU) / Standard 
Deviation (pooled) and applying a correction for the sample size. Cohen’s d effect sizes of 0.80 and 




treatment condition, as it does not take into account the impact of those stopping 
treatment early on the overall effectiveness of the treatment.  
 
In order to complete an ITT analysis, it was necessary to employ a method of 
replacing the data that was missing as a result of study drop-outs. Carpenter et al 
(2002) highlight four options that are available for this: 
1. Deletion of study-drop outs from the data analysis  
When using this method, all data completed by participants who drop-out of 
the study is removed from the analysis. This is a much less conservative 
method, as it produces a completer analysis rather than an ITT analysis and 
does not take into account the impact of those dropping out on a treatments 
overall effectiveness. 
2. Last Observation Carried Forward (LOCF)  
When using this method, participants’ last recorded score on an outcome 
measure is carried forward and used to replace the missing values for when the 
measure would have been completed if they had not dropped out. This method 
is conservative, in that the use of the last observation is not intended to inflate 
or deflate outcome scores for either treatment group. 
3. Design and build a statistical model to replace missing data 
This method uses the obtained data to determine a statistical model for the 
drop-out process. This is most useful with large samples and in studies where 
drop-out is considered a non-random event. Given that the sample size is 
relatively small in the current study, there would be insufficient numbers to 





4. Replacing missing data for study drop-outs with the group mean  
In this method the measures that are missing as a result of drop-out are 
replaced with the group mean. This can have the effect of either inflating or 
deflating outcome scores depending on the group means.  
 
Based on the evidence outlined above, only options two and four were possible in the 
current study. Option one produces a completer analysis and therefore does not 
account for the impact of those dropping out of treatment. The sample size was too 
small to consider option three as a possibility. Option two was chosen over option 
four as the former was more conservative based on the obtained group means.  
 
3.3.3 Analysis of Treatment Outcome over Time by Treatment Group 
Table 3.7 summarises the means and standard deviations for all the outcome measures 
completed by the two treatment groups. As an initial step in the analysis independent 
t-tests were conducted between the two treatment groups on all the pre-treatment 
outcome measures to determine if there were any significant differences between the 
two treatment groups prior to commencing treatment. Results of these t-tests indicated 
that participants scores on the outcome measures did not significantly differ between 
the two treatment groups at the pre-treatment assessment point: GDS: t (51) = .08, p = 
.93 (ns); GAI: t (51) = .40, p = .68 (ns); CORE-Total: t (51) = .56, p = .57 (ns); 
CORE-F: t (51) = .04, p = .97 (ns); CORE-P: t (51) = .22, p = .83 (ns); CORE-W: t 
(51) = .74, p = .46 (ns). This suggests both treatment groups had equivalent levels of 















Mean SD Mean SD 
 
Geriatric Depression Scale 
    
Pre-treatment 21.09 5.47 20.95 6.03 
Post-treatment 12.88 8.92 19.70 6.60 
One Month Follow-up 12.91 8.26 19.30 7.83 
     
Geriatric Anxiety Inventory     
Pre-treatment 13.48 6.01 14.15 5.53 
Post-treatment 8.70 5.94 12.05 5.46 
One Month Follow-up 8.52 6.36 12.75 5.95 
     
CORE - Total     
Pre-treatment 52.30 18.14 49.50 16.89 
Post-treatment 37.33 17.82 51.75 16.66 
One Month Follow-up 34.82 20.46 47.05 20.08 
     
CORE - W     
Pre-treatment 8.76 3.08 8.10 3.24 
Post-treatment 6.58 3.87 8.50 3.67 
One Month Follow-up 6.24 4.66 8.60 3.93 
     
CORE - P     
Pre-treatment 24.39 9.41 23.80 10.11 
Post-treatment 17.09 7.70 25.00 9.14 
One Month Follow-up 16.48 9.51 22.10 10.34 
     
CORE - R     
Pre-treatment 1.79 2.42 .60 1.05 
Post-treatment .88 1.51 .35 .99 
One Month Follow-up .85 1.56 .55 1.37 
     
CORE - F     
Pre-treatment 17.12 6.99 17.05 6.85 
Post-treatment 12.03 7.05 17.90 6.34 
One Month Follow-up 11.36 7.85 15.60 5.42 
 
 
A series of 2 (Treatment Group) x 3 (Time) ANOVAs, with time as the repeated 
measure were conducted in order to examine the two treatment group’s outcome over 
time, for each of the outcome measures listed in Table 3.7, for each of the outcome 





Mauchley’s test of sphericity was significant for the GDS (χ
2 
(2) = 18.09, p < .001) 
and as the sphericity measure was < .75 the Greenhouse-Geisser correction was used 
to adjust the degrees of freedom (df). Similarly, Mauchley’s tests of sphericity for the 
CORE-Total was significant (χ
2 
(2) = 7.81, p = < .05) and as the sphericity measure 
was > .75 the Huynh-Feldt correction was used to adjust the degrees of freedom (d.f.). 
Mauchley’s test was not significant for the GAI, the CORE-P, the CORE-F and the 
CORE-W. Therefore, no corrections were required for each of theses measures
8
. The 
results of the repeated measures ANOVA are summarised in Table 3.8. 
 
Table 3.8 highlights that there was a significant main effect of time (GDS: F (1.53, 
78.24) = 28.60, p < .001; GAI: F (2, 102) = 21.69 p < .001; CORE-Total: F (1.84, 
93.81) = 17.24, p < .001; CORE-W: F (2, 102) = 3.09, p < .01; CORE-P: F (2, 102) = 
15.02, p < .001 and CORE-F: F (2, 102) = 10.81, p < .001)) for all the outcome 
measures. This suggests that when the two treatment groups (i.e. BTB+TAU vs. 
TAU) are not considered, there was a significant reduction in all of the outcome 
measures over the course of treatment. Pairwise comparisons revealed that for each of 
the outcome measures there was a significant reduction between the pre-treatment and 
the post-treatment assessment points, and the pre-treatment and one month follow-up 
assessment points. There was, however, no significant difference between the post-






                                                 
8
 When the Greenhouse-Geisser and the Huynh-Feldt corrections were not applied to the GDS and 




Table 3.8 Repeated measures ANOVA of time (pre-treatment, post-treatment, one 
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Table 3.7 also shows there was a significant main effect of group for the GDS (F (1, 
51) = 5.17, p < .05). For all the other outcome measures the main effect of group was 
non-significant (GAI: F (1, 51) = 3.17, p = .08 (ns); CORE-Total: F (1, 51) = 2.79, p 
= .10 (ns); CORE-W: F (1, 51) = 1.60, p = .21 (ns); CORE-P: F (1, 51) = 3.67, p = .06 
ns; CORE-F: F (1, 51) = 3.16, p = .08 (ns)). This indicates that if time of assessment 
is not taken into account (i.e. pre, post, one month follow-up) then there were no 
significant differences between the two treatment groups on the outcome measures 
with the exception of the GDS. Analysis of the means indicates those in the 
BTB+TAU had significantly lower scores on the GDS than the TAU group when time 
of assessment is not considered. 
 
Table 3.8 also highlights the significant time x group interactions for the GDS (F 
(1.53, 78.24) = 14.02, p < .001) the GAI (F (2, 102) = 5.09, p < .01) the CORE-Total 




CORE-P (F (2, 102) = 12.29, p < .001) and the CORE-F (F (2, 102) = 7.76, p < .01 . 
These results suggest that for each of the outcome measures there was a significant 
difference in how the two treatment groups responded over time. These interactions 




Figure 3.2 Mean GDS scores by treatment group over time 
 
 
As there are only two treatment groups in the current study, post hoc tests to evaluate 
the interaction between treatment group and time were not produced by SPSS. As 
only one t-test is required to evaluate differences between the two treatment groups at 
the different assessment time points, this does not inflate the familywise error rate 
(Field, 2009). Therefore, independent t-tests were used to explore the interactions 
illustrated in Table 3.8.  
 
For the GDS, independent t-tests showed a statistically significant difference between 
the BTB+TAU and the TAU group by the post treatment assessment point (t (51) = 
2.96, p < .01) with the BTB+TAU group having significantly lower scores than the 




treatment were large (d = .85). These results suggest that, in comparison to the TAU 
group, the BTB+TAU group showed significantly greater improvements in their 
symptoms of depression by the end of treatment. Furthermore, these improvements 
were maintained by the one month follow-up point (t (51) = 2.78, p < .01). Effect 
sizes in favour of BTB+TAU over TAU at the one month follow-up point on the GDS 
were moderate (d = .80). As described previously, due to the design of the current 
study, interpretation of these results in terns of drawing any conclusions about the 
effectiveness of BTB, have to be treated with caution.  
 
 
Figure 3.3 Mean GAI scores by treatment group over time 
 
Independent t-tests on the GAI showed a significant difference between the 
BTB+TAU and the TAU group by the post treatment assessment point (t (51) = 2.05, 
p < .05) with the BTB+TAU group having significantly lower scores than the TAU 
group on the GAI. Effect sizes in favour of BTB+TAU over TAU at the end of 
treatment were moderate (d = .59). These results suggest that, in comparison to the 
TAU group, the BTB+TAU group showed significantly greater improvements in their 




by the one month follow-up point (t (51) = 2.40, p < .05). Effect sizes in favour of 
BTB+TAU over TAU on the GAI at the one month follow-up were moderate (d = 
.69). As described previously, due to the design of the current study, interpretation of 
these results in terns of drawing conclusions about the effectiveness of BTB, have to 




Figure 3.4 Mean CORE-total scores by treatment group over time 
 
 
Independent t-tests on the CORE-Total showed a significant difference between the 
BTB+TAU and the TAU group by the post-treatment assessment point (t (51) = 2.92, 
p < .01) with the BTB+TAU group having significantly lower scores than the TAU 
group on the CORE-Total. Effect sizes in favour of BTB+TAU over TAU at the end 
of treatment were large (d = .84). This suggests that, in comparison to the TAU 
group, the BTB+TAU group showed significantly greater improvements in their 
symptoms over the course of treatment. These improvements were maintained by the 
one month follow-up point (t (51) = 2.23, p < .05). Effect sizes in favour of 
BTB+TAU over TAU on the CORE-Total at the one month follow-up were moderate 




interpretation of these results in terns of drawing conclusions about the effectiveness 
of BTB, have to be treated with caution. 
 
For the CORE-P subscale there was a significant difference between the TAU and 
BTB+TAU group by the end of treatment (t (51) = 3.37, p < .001) and at the one 
month follow-up assessment point (t (51) = 2.01, p < .05), indicating (in comparison 
to the TAU group) the BTB+TAU group showed significantly greater improvements 
over the course of treatment and at one month follow-up. A similar pattern was found 
with the CORE-F subscale, whereby there was a significant difference between the 
TAU and BTB+TAU group by the end of treatment (t (51) = 3.37, p < .001) and at the 
one month follow-up assessment point (t (51) = 2.01, p < .05), indicating that in 
comparison to the TAU group, the BTB+TAU group showed significantly greater 
improvements over the course of treatment and at one month follow-up. There were, 
however, no significant differences between the two treatment groups on the CORE-
W subscale at the post-treatment (t (51) = 1.78, p = .08 ns) and the one month follow-
up assessment points (t (51) = 1.89, p = .065 ns).  
 
3.3.3.1 Multivariate Analysis 
Due to the fact that several separate ANOVAs were conducted for each of the 
dependent variables (DV’s) used in the study, this can potentially inflate the 
familywise error rate, particularly if there is a partial overlap in the underlying 
construct being examined by each of the DV’s (Field, 2009). The use of Multivariate 
Analysis of Variance (MANOVA) helps reduce this by incorporating several 
dependent variables, which may share an association with each other, into a new 




combination of dependent variables.  Two MANOVAs were therefore conducted: 
firstly by incorporating the GDS, GAI and CORE-total scores to give an overall 
assessment of mood; and secondly by combining the subscales of the CORE (rather 
than separate ANOVAs for each subscale.  
 
The results of the MANOVAs showed that there was a significant difference between 
the TAU group and the BTB+TAU group in terms of an overall assessment of their 
mood (GDS, GAI and CORE-total composite) with the BTB+TAU group having 
significantly lower scores (F (3, 49) = 3.14, p < .05; Pilai’s Trace = .16) by the end of 
treatment. The same pattern of results was observed for the MANOVA incorporating 
the subscales of the CORE (F (4, 49) = 5.19, p < .001; Pilai’s Trace = .30). These 
results appear to lend additional support to the main treatment effects reported in 
section 3.3.1.   
 
3.3.4 Examination of Clinically Significant Improvement 
The results thus far have been examined in terms of their statistical significance. 
However, Jacobson and Truax (1991) suggest statistical tests are used primarily to 
determine if a treatment effect actually exists (i.e. if the results are statistically 
significant in favour of a particular treatment it can be inferred that the findings are 
produced by the treatment, as opposed to by chance).  However, Jacobson and Truax 
(1991) argue that statistically significant findings in favour of a particular treatment 
have little to do with the clinical significance of the treatment (i.e. the size and 
importance of what the treatment does in actual practice). These authors describe an 
example to illustrate this point, whereby a treatment for obesity results in a mean 




Statistical analysis shows these results are significant in favour of the obesity 
treatment. However, the clinical significance of loosing 2lb from a treatment can be 
questioned.  
 
Jacobson and Truax (1991) therefore argue that following statistical examination, 
further analysis of outcome data is required in order to determine the clinical 
significance of any treatment effects. The most conservative method proposed by 
Jacobson and Truax (1991) is to assess whether a participant’s outcome by the end of 
treatment is two standard deviations from the mean (in the direction of improvement) 
of the ‘dysfunctional population’ (i.e. the treatment group prior to starting treatment. 
This method was therefore used to determine the number of participants within each 
treatment group who did or did not meet clinically significant improvement criteria by 
the end of treatment and at one month follow-up). The methods outlined by Jacobson 
and Truax (1991) were also used in other studies of BTB to determine the clinical 
significance of the treatment (e.g. Cavanagh et al, 2006; Learmonth and Rai, 2008; 
Learmonth et al, 2008).  The results are summarised in Table 3.8.  
 
As can be seen from Table 3.8, in comparison to the TAU group, a significantly 
greater number of participants in the BTB+TAU group met criteria for clinically 
significant improvement on the GDS by the post treatment assessment point (χ2 (1) = 
5.30, p < .05) and by the one month follow-up assessment point (χ2 (1) = 7.18, p < 
.01). Similarly, in comparison to the TAU group a higher percentage of participants in 
the BTB+TAU group met criteria for clinically significant improvement on the GAI 
and the CORE-Total, but these differences were not statistically significant. As 




results in terns of drawing conclusions about the effectiveness of BTB, have to be 
treated with caution. 
 
Table 3.8 Number and percentage of participants who meeting criteria for clinically 
significant improvement by post treatment and one month follow-up 
 
 
BTB+TAU TAU Summary Statistics 
 
 
Yes (%) No (%) Yes (%) No (%) χ2 d.f. p 
By Post-Treatment        
GDS 13 (39.4) 20 (60.6) 2 (10) 18 (90) 5.30 1 .021 
GAI 6 (18.2) 27 (81.8) 0 (0) 20 (100) 4.10* 1 .072 ns 
CORE-T 5 (15.2) 28 (84.8) 0 (0) 20 (100) 3.34* 1 .144 ns 
        
By 1 month F/U        
GDS 14 (42.4) 19 (57.6) 2 (10) 18 (90) 7.18 1 .007 
GAI 9 (27.3) 24 (72.7) 1 (5) 19 (90) 4.03* 1 .070 ns 
CORE-T 6 (18.2) 27 (81.8) 1 (5) 19 (90) 1.88* 1 .233 ns 
        
*Fisher’s exact test statistic was used due to expected frequencies < 5 
 
 
3.4 EXAMINATION OF TAU RECEIVED BY PARTICIPANTS 
3.4.1 Psychotropic Medication 
A high percentage of participants (85 per cent) reported being prescribed psychotropic 
medication as part of the treatment as usual they were receiving at the start of the 
study. In terms of the classifications of psychotropic medication that was prescribed 
to participants, the majority reported receiving antidepressant medication (86.7 per 
cent). Twenty-four percent of participants were also prescribed benzodiazepine 
medication. There were no significant differences between the BTB+TAU group and 
the TAU groups in terms of the percentage of participants who were receiving 
psychotropic medication at the start of the study (χ
2
 (1) = 2.55, p = .234 (ns)) .  All 
participants reported being prescribed psychotropic medication for at least a month 





As the study was not primarily concerned with the specific effectiveness of 
psychotropic medications, specific details about the dosages or the prescription 
protocols were not collected as this was beyond the scope of what was possible in the 
study.  Similarly, it was beyond the scope of the study to accurately assess participant 
adherence to medication or collect accurate details regarding changes in the 
prescribed dosage of medication. Information was, however, collected regarding 
whether participants continued to be prescribed and whether they reported continuing 
to take psychotropic medication. This revealed all participants who were prescribed 
psychotropic medication at the start of the study continued to take this by the end of 
the study. One participant who was not prescribed psychotropic medication at the start 
of the study reported being commenced on this by the end of the study. This 
participant was within the BTB+TAU group. They discontinued BTB after session 
four and overall had a poor treatment response in terms of reductions in their scores 
on the outcome measures.  
 
3.4.2 Psychological Treatment  
An exclusion criterion for the study was that participants should not be receiving face-
to-face psychological therapy from an accredited therapist during their participation. 
Overall this was adhered to well, as monitored through examining incoming referrals 
to the clinical psychology department where participants would have been referred. 
However, two participants in the BTB+TAU group were referred for face-to-face 
psychological therapy. Both participants discontinued BTB (at session four and five 
respectively) before they were referred for face-to-face treatment. They had not 




Both participants reported receiving one assessment session by the one-month follow-
up point.  
 
3.4.3 Other Treatment as Usual Received 
In terms of the other treatment as usual that was received by participants this tended 
to vary, which may have been the result of limited constraints being placed on this 
condition. An in-depth analysis of the additional treatment as usual that was received 
was limited by the information that was possible to obtain from the clinicians 
providing this treatment.  As described in the previous sections, a high percentage of 
participants in both groups received psychotropic medications but did not receive 
active psychological therapy from an accredited therapist as part of their treatment as 
usual. These two aspects could be monitored accurately by examining the incoming 
referrals to the clinical psychology service that participants would have been referred 
to, and asking what medication they were prescribed at the end of treatment.  In 
addition, 14 participants (11 in the TAU group and 3 in the BTB+TAU group) 
attended a day hospital. The primary purpose of this was reported as providing social 
support and advice regarding managing their difficulties. Six participants had contact 
with a psychiatrist (2 in the TAU group and 4 in the BTB+TAU group) at outpatient 
clinics with the primary purpose of reviewing medication. Lastly, 23 participants 
received contact with a Community Psychiatric Nurse, Support Worker or Care 
Manager. The primary purpose of these contacts was reported as social support and 
advice regarding managing their difficulties, including in some instances the 






CHAPTER 4 – DISCUSSION 
4.1 RESEARCH OVERVIEW 
Although a number of studies (Proudfoot et al, 2003b; Proudfoot et al, 2004; Grime, 
2004; Cavanagh et al, 2006; Mitchell & Dunn, 2007; Learmonth & Rai, 2008; 
Learmonth et al, 2008; Cavanagh et al, 2011) have suggested that Beating the Blues 
(BTB) is an effective treatment for depression and anxiety with adults of working age, 
until now no study has examined the use of this treatment with older people in actual 
routine practice (but see Elsegood & Powell, 2008). The main purpose of conducting 
the current study was to begin to address this gap in the literature, with the primary 
focus on determining the acceptability and feasibility of the use of BTB with older 
people as well as beginning to tentatively examine whether it is an effective treatment 
for this population. The design of the study, however, means that interpretation of the 
results in relation to this latter area should be treated with a degree of caution. This is 
discussed further below. Specific aims of the study were to explore the acceptability 
of BTB with older people in terms of the rate of uptake of the treatment, determine 
some of the participant characteristics that influence the uptake of BTB with older 
people, explore the acceptability of BTB with older people in terms of the treatment 
discontinuation rate and finally to make an initial evaluation of whether BTB is an 
effective treatment in reducing symptoms of depression and anxiety in older people. 
Due to the design of the study, which was a pilot study primarily to examine the 
acceptability and feasibility of BTB with older people, any conclusions with regard to 
the treatments effectiveness should be treated with caution.   
 
It was found that, when given a free choice of whether or not they wished to receive 




treatment and completed at least one session (see Figure 3.1, page 101). It was also 
found that in comparison to those who declined to receive BTB, participants who 
agreed to receive this treatment reported having significantly more experience and 
confidence with using computers and were more likely to have the internet at home. 
They were also significantly younger (71.58 years vs. 75.55 years) and significantly 
more educated (11.70 years of education vs. 10.25 years of education). However, 
based on the mean values, the clinical importance of these latter two findings may be 
relatively small.  
 
Participants who opted for BTB did not, however, appear to be any less ‘ill’ than those 
who declined BTB (i.e. participants in both groups did not significantly differ in terms 
of: 1) their psychiatric history; 2) the duration of their current episode; 3) whether 
they were currently taking psychotropic medication; 4) the number of co-morbid 
physical illnesses they reported; and 5) the severity of their symptoms of depression 
and anxiety prior to starting the study). 
 
In terms of the rate of discontinuing BTB before the last session (27.3 per cent) the 
findings are similar to what has been found in pervious research of BTB with adults of 
working age. (see section 4.3 below).  
 
In terms of treatment outcome, the results indicated that, in comparison to the TAU 
group, those in the BTB+TAU had significantly greater reductions in their symptoms 
of depression and anxiety over the course of treatment and after a one month follow-
up. This could suggest BTB (combined with treatment as usual) may be more 




anxiety in older people. Such a conclusion should, however, be treated with a degree 
of caution due to the methodology used in the current study, which did not randomly 
allocate participants to the treatment groups. The fact that participants were able to 
choose which treatment group they wished to be part of may suggest that the 
participants in the BTB+TAU group were highly motivated and keen to receive this 
treatment. It could be argued that this may have facilitated their treatment outcome (in 
comparison to the impact BTB would have when there was an even number of 
participants who were not as motivated to use this treatment). This potentially limits 
the extent to which the findings can be generalised to the wider population (i.e. 
including individuals who may not be as motivated to receive this treatment) and 
means any conclusions made about the effectiveness of BTB should be treated with 
caution.  
 
In addition, compared to those in the TAU group, significantly more participants (39 
per cent) in the BTB+TAU group showed clinically significant reductions in their 
symptoms of depression as measured by the GDS by the end of treatment and after 
one month follow-up. There were also more participants in the BTB+TAU group 
compared to the TAU group who reported clinically significant improvements in their 
symptoms of anxiety as measured by the GAI at the end of treatment and at one 
month follow-up, although the difference in the numbers of participants achieving 
clinically significant improvements between the two groups was not statistically 
significant. A similar pattern was found on the CORE-total.  
 
All these findings are discussed in greater detail below with reference to the results 




and the clinical relevance of the findings will be highlighted together with the 
implications for future research and service provision. The strengths and limitations of 
the study will also be discussed. 
 
4.2 UPTAKE OF BTB WITH OLDER PEOPLE 
4.2.1 Context 
The first aim of the study was to explore the acceptability of BTB to older people in 
terms of the number of participants who, when given a free choice, firstly agreed to 
take part in the study and then subsequently opted to receive BTB, relative to those 
who agreed to take part but declined to receive BTB. A similar methodology has been 
used for exploring the acceptability and effectiveness of group versus face-to-face 
CBT for treating anxiety in adults of working age (Sharp et al, 2004). This has also 
been advocated as a methodology that should be incorporated into future studies of 
CCBT to explore its acceptability (Kaltenthaler et al, 2006).  
 
Kaltenthaler et al (2008) highlight that there has been a lack of research that has 
focused on the acceptability of CCBT and what little there has been has often 
involved satisfaction surveys (often with participants who have completed the full 
course of treatment). It could be argued that any findings using this method may be 
biased as they may not take into account the views of those dropping out of treatment, 
or the individuals who refused to participate at all. The current study therefore 
contributes to the limited evidence base on the acceptability of BTB and is the first to 





Kaltenthaler et al (2008) also argue that the first step in evaluating the acceptability of 
CCBT should be to explore the rate of uptake of this treatment. More specifically, the 
reason for this is that even if a treatment is found to be effective in reducing a 
particular problem, if no one accepts it when it is offered it is likely to have little 
clinical use.  Kaltenthaler et al (2008) define the rate of uptake as the percentage of 
individuals who agree to begin CCBT relative to the total number of individuals who 
are approached and who decline. This approach to exploring the acceptability of BTB 
is particularly important with regard to the viability of BTB with older people, where 
previously a common assumption has been that older people will not accept CCBT 
packages such as BTB, despite some limited evidence to the contrary (Elsegood & 
Powel, 2008).   
 
An important point in relation to the uptake rate as an index of a treatments 
acceptability is that the uptake rate in an RCT may be confounded by the fact that 
participants do not receive a choice regarding the treatment they receive. The rate of 
uptake in an RCT is therefore defined by the number of individuals agreeing to 
participate in the study relative to the number who decline to participate. However, it 
has been highlighted that refusal to participate in a study may be a reflection of a 
reluctance to participate in any study, regardless of the treatment, rather than finding a 
specific treatment unacceptable (Kaltenthaler et al, 2008). Refusal to participate in an 
RCT could also potentially be a result of an individual finding the control condition 
unacceptable, rather than finding the specific treatment under investigation 
unacceptable.  Exploring the rate of uptake in an RCT can therefore potentially under-
represent the uptake rate of a treatment in actual practice, unless specific reasons for 




BTB. The only study of BTB that specifically discusses this issue is Grime (2004), 
where it was found that some individuals refused to participate in the study, as their 
employer would have to be informed they were taking part. It could be argued that 
such a reason for non-participation is not about finding BTB unacceptable per se, but 
rather finding the conditions of the study unacceptable. The detailed exploration of 
reasons for non-participation, however, raises ethical and practical issues as it is an 
ethical requirement that individuals do not have to give reasons for non-participation, 
and they may be reluctant to provide any reasons. Indeed, Grime (2004) found that 
only 42 per cent of non-participants gave reasons for not wishing to take part, which 
may therefore bias any conclusions that can be drawn from using this method.  
 
4.2.2 Uptake Rates of BTB  
The current study found that, in terms of the total number who agreed to participate in 
the study, 65.5 per cent opted to receive BTB. However, it was evident that five of 
these participants dropped out of the study prior to attending their first session of BTB 
(and without completing any treatment outcome measures). These individuals were 
removed from any subsequent treatment outcome analysis. A more conservative 
analysis of the uptake rate, which includes only those who attended at least one 
session of BTB, indicated that 56.9 per cent was therefore found with older people in 
the current study. This is compared to what has been found in previous research of 
BTB with adults of working age in Table 4.1.  
 
As can be seen from Table 4.1, the uptake rate of 56.9 per cent found in the current 
study is lower than what is found in previous studies, with only Grime (2004)  




rate found in the study by Grime (2004) may have been in part a result of some 
potential participants finding the conditions of the study unacceptable.  
 
Table 4.1 Uptake rates of BTB 
Study Total Approached 
& Eligible for BTB 
Total Starting BTB / 
Participating in RCT 
Uptake Rate 
Proudfoot et al (2004)* 406 274 (146 BTB) 67.5% 
Grime (2004) 155 48 (24 BTB) 30.9% 
Van den Berg et al (2004) not reported 13 not reported 
Cavanagh et al (2006) not reported 219 not reported 
Mitchell & Dunn (2007) 12 12 100% 
Learmonth & Rai (2008) not reported 104 75%** 
Learmonth et al (2008) 829 555 67% 
Cavanagh et al (2011) 432 295 68.2% 
Current study 58 33 56.9% 
*this included data from Proudfoot et al (2003b) as Proudfoot et al (2004) was a combined analysis.  
**This uptake rate was reported as an approximation by Learmonth & Rai (2008) but they did not state 
exactly how many individuals were offered BTB 
 
A discussion of participant characteristics that may influence the rate of uptake of 
BTB found in the current study is presented in section 4.2.4. Despite a lower uptake 
rate of BTB in the current study compared to previous research on BTB, the uptake 
rate found in the current study is, however, comparable to a recent RCT exploring 
face-to-face CBT for treating depression in older people where an uptake rate of 55.5 
per cent was found (Laidlaw et al, 2008).  
 
4.2.3 Participant Characteristics Influencing Uptake of BTB 
The second aim of the study was to explore the characteristics of participants that 
influence whether or not they opted to receive BTB. Previous research on BTB has 
been limited in terms of evaluating the characteristics of individuals that may 
influence whether or not participants agree to start BTB. Cavanagh et al (2011) 
explored this in a population of working age adults by comparing the ethnicity, age, 




conditions and pre-treatment severity of depression, anxiety and general wellbeing, in 
those who met their study inclusion criteria and started BTB, to those who met the 
inclusion criteria but opted not to complete any BTB treatment sessions. The results 
indicated that there were no significant differences between the two groups on any of 
these characteristics. They did, however, find a significant difference in terms of 
clinical ‘caseness’, whereby individuals who scored above clinical cut-offs on the 
outcome measures were more likely to start BTB than those who scored below these 
cut-offs (Cavanagh et al, 2011).  
 
Grime (2004) also reported on the age and gender characteristics of working age 
adults who declined to participate in an RCT of BTB with adults of working age, but 
did not compare these characteristics to those who did agree to participate. Grime 
(2004) did, however, describe some of the reasons individuals gave for not wishing to 
participate and highlights that only a minority declined to participate due to a specific 
reluctance regarding using BTB itself (e.g. disliking computers or thinking BTB would 
be unhelpful). The primary reasons for non-participation were reported to relate more 
to individuals feeling they could not take time off work to travel to appointments and 
feeling anxious about their employer finding out about their participation or being 
unsupportive. The full extent of these findings should be treated with caution, as 
reasons from only 42 per cent of non-participants were obtained, which could 
potentially mean other reasons for non-participation were not identified. Nevertheless, 
many of the findings that were reported for non-participation would be less applicable 





In the current study, as described previously, it was found that in comparison to those 
who declined to receive BTB, participants who agreed to receive this treatment 
reported having more experience and confidence with using computers and were more 
likely to have the internet at home. They were also significantly younger (71.58 years 
vs. 75.55 years) and significantly more educated (11.70 years of education vs. 10.25 
years of education). These findings are fairly consistent with what would be expected 
and the clinical importance of the latter two findings may be relatively minor, due to 
relatively small differences between the actual mean values.  
 
These findings can help inform the types of patients who are currently more likely to 
accept BTB, but more importantly highlight areas that could be targeted to help 
increase the likelihood of individuals who may benefit from BTB being willing to try 
it. This could potentially help bring the uptake rate with older people more in line 
with what has been found with younger age cohorts.  For example, it was evident that 
overall, individuals with lower reported levels of confidence in using a computer were 
less likely to accept BTB.  A future expansion could be to develop a computer skills 
training course to help increase older people’s confidence and experience in using a 
computer prior to BTB being offered. A potential barrier may be that individuals who 
are inexperienced and lack confidence may be reluctant to try such a course. 
However, a qualitative study by the Office of Communications (Ofcom, 2006), which 
explored older peoples use of computer technology and the internet, highlighted that 
the majority of older people who did not use computers were classified as 
‘disengaged’ rather than ‘rejecters’ (i.e. the disengaged non-users would be willing to 
learn to use computer technology given the right circumstances and if the correct 




such skills). This study highlighted that computer training courses designed and run 
by older people could potentially help other older people who have little computer 
experience become more engaged. It could also be argued that this will become less 
and less of an issue in the coming years, as larger cohorts of individuals who are 
experienced in using a computer will reach the age of 65 years. In line with this, data 
from the Office for National Statistics (Randall, 2010) suggests that the number of 
older people who have access to an internet connection in their home has risen by 26 
per cent in the year 2000 to 2008.  This may be assisted further by UK government 
initiatives to increase individuals having access to the internet and computer 
technology (Lane, 2010; Scottish Government, 2011), with a specific focus on 
marginalised groups such as older people.  
 
A further important finding in relation to the characteristics of the participants who 
opted for BTB were not, however, any less ‘ill’ than those who declined BTB (i.e. 
participants in both groups did not significantly differ in terms of: 1) their psychiatric 
history; 2) the duration of their current episode; 3) whether they were currently taking 
psychotropic medication; 4) the number of co-morbid physical illnesses they reported; 
and 5) the severity of their symptoms of depression and anxiety at the start of the 
study as assessed by their scores on the outcome measures prior to starting treatment. 
These findings challenge any assumptions that older people with, for example, more 
physical health problems will be reluctant to try new treatments such as BTB. An 
argument could also be made that it is older individuals who may have more physical 
health conditions that may make them less mobile than younger populations, where 
treatments such as BTB, which can be done over the internet in their own home, may 




accepting BTB is also in line with the findings from study by the Office of 
Communications (2006), which found individuals who did not use computer 
technology were no more ill than those who did use it.  
 
An important point to make is that although the current study identified a profile of 
some of the characteristics that may influence whether older people opt to receive 
BTB, this is by no means exhaustive. Future research could explore other 
characteristics that may influence the uptake of BTB, such as perceptions about the 
credibility of the treatment or individuals’ expectations for how much they perceive it 
would help treat their symptoms of depression and anxiety, which have been factors 
associated with uptake and outcome from CCBT (de Graff et al, 2009). In addition, 
the characteristics found in the current study should not be used as exclusion criteria 
for denying the option of receiving BTB to individuals deviating from these 
characteristics. Indeed, it was found that a minority of individuals with no experience 
or confidence in using a computer and with no access to the internet at home still 
opted to receive BTB and completed all eight sessions. This could indicate another 
underlying characteristic that is an important mediating factor that influences whether 
older people accept BTB. A further area that could be explored is whether levels of 
self-efficacy play a role in influencing the acceptability of BTB. At present the 
obtained profile can be useful for identifying some of the targets for intervention that 
may improve the acceptability of BTB to older people.  
 
4.3 RATES OF DISCONTINUATION OF BTB 
The third aim of the study was to explore the discontinuation rate of BTB with older 




(Kaltenthaler et al, 2008). Of the 33 participants who started BTB nine participants 
subsequently discontinued using the program before the eighth session, giving a 
discontinuation rate of 27.3 per cent. Table 4.2 summarises the discontinuation rates, 
together with the mean number of sessions that were completed prior to 
discontinuation, for the other studies that have examined BTB with adults of working 
age to allow a comparison with the current study.  
 
Table 4.2 Discontinuation rates of BTB 
Study Discontinuation  
Rate 
Mean number of sessions completed 
prior to discontinuation 
Proudfoot et al (2004)* 27.4% not reported 
Grime (2004) 33.3% 3.1 
Van den Berg et al (2004) 0%** not reported 
Cavanagh et al (2006) 38.4% not reported 
Mitchell & Dunn (2007) 16.7% 3.5 
Learmonth & Rai (2008) 31.7% 3.8 
Learmonth et al (2008) 29% 3.5 
Cavanagh et al (2011) 47.1% not reported 
Current study 27.3% 3.3 
*this included data from Proudfoot et al (2003b) as Proudfoot et al (2004) was a combined analysis.  
**This should be treated with caution as the authors only reported on a cohort of 12 participants who 
had completed all 8 sessions of BTB 
 
As can be seen from Table 4.2, the discontinuation rate found in the current study is 
comparable to what has been found in previous studies of BTB. If the study by Van 
den Berg et al (2004) is not included, the mean discontinuation rate for the studies 
reporting on this issue is 31.9 per cent. The rate found in the current study is slightly 
below this at 27.3 per cent.  
 
It was also evident that the average number of sessions at which participants drop-out 
is between the third and fourth session. It could also be argued that the modal number 
of sessions at which participants discontinue BTB would also be helpful to analyse. In 




four. It was not, however, possible to calculate the modal value at which participants 
discontinued BTB in any of the other studies listed in Table 4.2. It may be helpful to 
explore further in future research the sessions at which participants discontinue BTB, 
for example, to examine whether or not there are particular aspects of the program 
that increases the likelihood of discontinuing (e.g. is there particular aspects at session 
3 - 4 that some participants find off putting). This could potentially be undertaken 
with qualitative methods to try and gain more in-depth information about participants 
reasons for discontinuing BTB.  
 
Within the current study it was evident that there was a range of reasons participants 
gave for discontinuing BTB, with all but two participants reporting a different reason 
(see Table 3.4, p 94). It was, however, noted that only one participant who 
discontinued BTB reported that they found BTB unhelpful and another reported that 
the computer was too difficult to use. The reasons provided by participants do, 
however, need to be treated with a degree of caution, as a detailed exploration of the 
reasons for discontinuing treatment was beyond the scope of the current study. It was 
also an ethical requirement that participants did not have to provide reasons for 
discontinuing, although in the current study many participants spontaneously provided 
brief reasons for discontinuing BTB. Kaltenthaler et al (2008) have advocated that 
future research should use detailed qualitative methodologies to explore factors such 
as participants experience of using BTB and factors that relate to discontinuing 
treatment early, as there is a paucity of information about this. The current study 
provides some initial relevant information with older people. Ethical approval has 




factors in more detail with participants from the current study, as well as reasons that 
may have influenced their decision as to whether or not to opt for BTB.   
 
It was also apparent in the current study that a higher percentage of participants in the 
BTB+TAU group discontinued BTB than the percentage of participants in the TAU 
group who dropped out of the study. The differences were not, however, statistically 
significant.  
 
4.4 TREATMENT OUTCOME – Secondary aim 
The secondary aim of the study was to begin to tentatively explore the effectiveness 
of BTB for treating symptoms of depression and anxiety in older people, with the 
caution that the study was primarily a pilot study and not a controlled effectiveness 
study. The results showed that, in comparison to the TAU group, the BTB+TAU 
group had statistically, and clinically significant, greater improvements in symptoms 
of depression and anxiety by the end of treatment and at one month follow-up. The 
results also suggested that there were not significant differences found between the 
two groups in the content or amount of treatment as usual that was received (e.g. in 
comparison to the TAU group the BTB+TAU did not have a higher proportion of 
participants who were prescribed psychotropic medication). This limits the extent to 
which the significant differences found between the two groups, in terms of treatment 
outcome, could be accounted for by differences in the treatment as usual that was 
received. However, given the fact that participants were not randomly allocated to the 
treatment groups, combined with the non-specific and variable nature of treatment as 
usual, any interpretation about the extent to which the significant differences in 




rather than also being influenced by other factors, should be treated with caution. This 
issue is discussed further in the strengths and limitations section below.  
 
In addition, there did not appear to be any evidence suggesting that the TAU group 
was any more ‘unwell’ than the BTB+TAU group at the start of the study, as indexed 
by no significant differences between the two groups on pre-treatment levels of 
symptomatology, previous psychiatric history, use of concurrent psychotropic 
medication, number of co-morbid physical health problems and duration of current 
episode of illness.  
 
Table 4.3 summarises the main findings reported in previous studies of BTB with 
adults of working age in terms of the treatment effect sizes and percentages of 
participants meeting criteria for clinically significant improvement.
9
 This allows a 
comparison of the treatment effects found in the current study to previous research on 
BTB. As can be seen from Table 4.3, uncontrolled effect sizes and BTB compared to 
treatment as usual effect sizes ranged from .62 to .85 in favour of BTB for treating 
depression. This suggests BTB has a moderate to large treatment effect on symptoms 
of depression. The effect size of .80 in the current study is comparable to what has 
been found in the previous studies of BTB listed in Table 4.3 and suggests that it is no 
less effective with older people than with adults of working age for treating 
depression. A similar pattern can also be seen in terms of effect BTB has upon the 
CORE-total.  
 
                                                 
9
 All effect sizes and clinically significant improvement percentages were based on ITT samples (rather 
than completers samples when both were reported) at the end of treatment, to facilitate comparison 




Effect sizes on measures of anxiety were generally smaller across the previous studies 
of BTB listed in Table 4.3 that reported this, ranging from .37 to .90. The effect size in 
the current study of .59 compares favourably to the previous studies with younger 
adults (Proudfoot et al, 2003b; Proudfoot et al, 2004; Grime, 2004; Mitchell & Dunn, 
2007; Learmonth et al, 2008; Cavanagh et al, 2011). The fact that BTB appears to 
have less of an effect upon anxiety is possibly a reflection of the content of the 
program, which may be more targeted towards the treatment of symptoms of 
depression rather than anxiety.  
 
As highlighted in Table 4.3, an analysis of clinically significant improvements has 
only been made in four previous studies of BTB (Cavanagh et al, 2006; Learmonth & 
Rai; 2008; Learmonth et al, 2008; Cavanagh et al, 2008) and only the latter two 
studies report this specifically in relation to depression. The findings of clinically 
significant improvements in symptoms of depression in 39.4 per cent of participants 
in the current study compares favourably to the 21 per cent reported by Learmonth et 
al (2008) but is slightly below the 50 per cent reported by Cavanagh et al (2011). The 
fact that approximately 40 per cent of the sample in the current study met criteria for 
clinically significant improvements in their symptoms of depression, as measured by 
the GDS, by the end of treatment and at one month follow-up highlights the potential 
clinical impact this treatment may offer in actual clinical practice. 
 
The results of the current study do, however, highlight that a majority of participants 
did not meet criteria for clinically significant improvements on measures of 
depression. An important aspect in relation to this is that the BTB package that was 




Table 4.3 Summary of results from previous research on BTB
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Study Index Effect 
 Size 
 
% of participants achieving 
clinically significant 
improvement 


























































































*this included data from Proudfoot et al (2003b) as Proudfoot et al (2004) was a combined analysis.   
 
 
McAlpine (2008) highlight that there “remains a persistent question regarding the 
issue of modification and adaptation of CBT with older people” (p 251), despite a 
number of meta-analyses suggesting it is an equally efficacious treatment for 
                                                 
10
 The effect sizes for Proudfoot et al (2004) and Grime (2004) were not reported in the respective 
papers but were calculated using Cohen’s d (Mean (treatment) – Mean (control) / SD (pooled)) as per 
the method used in the current study. The remainder of the studies, which did not employ a control 





depression in older people as it is for younger adults. Indeed, as discussed above the 
current study produced outcomes with older people that are comparable to studies of 
BTB with younger adults.  Laidlaw and McAlpine (2008) suggest that despite such 
findings “it is interesting to speculate whether outcome could be enhanced if 
modifications, which take into account gerontological models of aging, are 
incorporated” (p 251). These authors, however, highlight that older people represent a 
heterogeneous group and that modifications to an already efficacious treatment should 
be based on need rather than age. However, they also suggest that conceptual 
modifications, rather than procedural modifications, that take into account the aging 
process may help enhance outcomes from CBT with older people. Laidlaw  and 
McAlpine (2008) suggest six conceptual issues that can be incorporation into the 
basic model of CBT that may enhance its use with older people including “1) 
incorporation of a comprehensive conceptualisation framework; 2) understanding the 
different time-frame older people operate within; 3) achieving goal-focussed 
optimized coping with loss experiences; 4) focussing on maintenance rather than 
cause in treatment; 5) understanding differences between generations (cohort); and 6) 
the assessment of suitability” (p 252).   
 
Somewhat paradoxically to the arguments made by Laidlaw and McAlpine (2008) 
described above, it was evident that as the version of BTB used in the current study 
was not adapted for use with older people (e.g. only one of the case study video 
vignettes used to illustrate key points in the treatment involves an older person). This 
leads to a hypothesis as to whether adapting the current version of BTB to include 
more vignettes specifically with older people would be helpful in further facilitating 




change, (which Laidlaw and McAlpine (2008) argue are not necessarily required in 
using CBT with older people), it was something that a number of the participants in 
the current study commented upon. It is possible that having a greater range of case 
study vignettes including a larger number of older people, incorporating differing 
older people age cohorts, may be more reflective of the heterogeneous nature of older 
people. This could potentially help illustrate some of the conceptual issues outlined by 
Laidlaw and McAlpine (2008). For example, it may allow different cohorts of older 
people and their differences to be more effectively incorporated into the treatment.  
 
In terms of the CORE-total and GAI, a smaller percentage of participants receiving 
BTB met clinically significant improvement criteria for these (15.2 and 18.2 per cent 
respectively), in comparison to the percentage meeting clinically significant 
improvement criteria on the GDS (39.4 per cent). This may lend further support to the 
suggestion that BTB is not as effective in treating symptoms of anxiety, compared to 
depression, particularly in older people as such disparities between the clinical impact 
of BTB on depression and anxiety were not found in two other studies which reported 
this with adults of working age (Cavanagh et al, 2011; Learmonth et al, 2008).  
 
However, of note, within the current study there were relatively large standard 
deviations on the CORE-total, which meant the criteria for reaching clinically 
significant improvement on this measure was very conservative. Similarly, the 
criterion for meeting clinically significant improvement on the GAI was extremely 
conservative and was well below the clinical cut-off defined by the developers of this 
measure for differentiating individuals within the normal range and clinical range (i.e. 




to below this by the end of treatment and were within the normal range on this 
measure but still did not reach criteria for clinically significant improvement). This 
could suggest that some participants in the current study may have reported anxiety 
symptoms on the GAI within the normal range by the end of treatment but may not 
have reached criteria for clinically significant improvement, which may attenuate the 
findings in terms of the number of participants achieving clinically significant change 
on the GAI.  
 
4.5 STUDY STRENGTHS AND LIMITATIONS 
Despite the findings outlined above, there were a number of limitations in the current 
study that should be noted. An argument could be made that as the study did not 
employ an RCT, which is often classed as the ‘gold standard’ of treatment outcome 
research, this could reduce the extent to which the results can be attributable to BTB 
as the lack of randomisation may have meant confounding variables were not evenly 
distributed between the two groups. For example, it was evident that there were 
significant differences between the two groups in terms of participants’ age and years 
of education, with the BTB+TAU group being significantly younger and more 
educated. Similarly, in comparison to the TAU group, the BTB+TAU group reported 
being significantly more confident and experienced in using a computer. Given that 
patients were also able to self-select which treatment group they wished to be part of, 
it could be argued that, although it was not directly measured in the current study, 
those participants who actively opted (as opposed to being than randomly allocation) 
to receive BTB were highly motivated about using this treatment. All of these factors 
could have potentially facilitated the outcomes obtained by participants in the 




randomly and evenly distributed participants in terms of their experience and 
confidence in using a computer and their motivation in using BTB).  This means any 
conclusions about the effectiveness of BTB in the current study have to be treated with 
caution. 
 
There was, however, some evidence to suggest that some important factors that could 
have affected outcome were evenly distributed between the two groups. For example, 
there were no significant differences between the groups on baseline levels of anxiety 
or depression, the reported duration of their current episode, the number of reported 
physical health problems, the use of psychotropic medication etc.  
 
As the group receiving BTB in the current study reported significantly higher 
confidence and experience in using a computer than those who declined BTB, this 
may limit the extent to which the findings can, at present, be generalised to those 
reporting low-levels of confidence and experience with using a computer. As noted 
previously, the methodology and design of the current study limits any conclusions 
that can be drawn about the effectiveness of BTB with older people, However, as the 
use of BTB with older people is an emerging research area the current study was an 
important initial step in providing some evidence towards demonstrating the 
acceptability and feasibility of the use of this treatment with older people. Future 
research could explore more rigorously the effectiveness of BTB, for example using 
an RCT, given that the results of the current study would lend support to the 
feasibility of this. As mentioned previously, future areas of development could also 
explore interventions to increase older peoples confidence in using computers and 




levels of improvements in those who initially reporting low levels of confidence in 
using a computer.  
 
Despite the potential for the design of the current study to include participants who 
had a strong preference to receive BTB being allocated to this treatment condition, 
which may facilitate the obtained outcome in favour of this treatment, the use rather 
than an RCT has a number of advantages in terms of the other aims of the study. It 
allowed an understanding of the percentage of older people who are likely to accept 
BTB when given a free choice about whether to receive it, which is more reflective of 
what would occur in actual practice. It also allowed a pragmatic evaluation of how 
acceptable this treatment is likely to be with older people in terms of the 
discontinuation rate and the clinical outcome achieved. As these areas were unknown 
prior to this study the feasibility of an RCT was unknown (i.e. it was not clear if older 
people would agree to be randomised to BTB). The current study could therefore be 
considered as a pilot study, demonstrating the acceptability and feasibility of the use 
of BTB with older people, that provides support for a larger scale RCT to be 
conducted. This would help identify if the results of the current study can be 
generalised to wider populations of older people and would allow firmer conclusions 
to be made regarding the efficacy of the treatment with older people. This could 
stratify allocation to treatment groups based on the levels of reported experience and 
confidence in using a computer. A future RCT could also employ additional control 
conditions that test non-specific aspects of the BTB treatment, such as the use of a 
potentially enjoyable computer program. Alternatively, it could explore the 
differential impact of another treatment patients are likely to have the option to 




In relation to the previous point regarding the feasibility of an RCT, the current study 
was relatively small in scale in terms of the number of participants (i.e. only 58 
participants were recruited). However, the obtained effect sizes were moderate to 
large, in line with previous research comparing BTB to treatment as usual with 
younger adults and meta-analyses of psychological treatments with older people. In 
addition, the significant findings obtained suggest that a type II error was avoided 
(post hoc power = .87 for depression and .65 for anxiety). The relatively small 
numbers recruited is also reflective of a number of other published studies evaluating 
psychological treatments with older people. For example, Laidlaw et al (2008) 
recruited 40 participants for their RCT examining face-to-face CBT with older people. 
Furthermore, a meta-analysis of 25 published studies examining psychological 
treatments for depression in older people (Cuijpers et al, 2006) highlighted that 14 of 
these studies has sample sizes that were smaller than the current study. However, it 
should be noted that many of these studies employed a range of designs, had different 
study durations, recruited participants with differing levels of severity and some were 
multi-site. This means that drawing direct comparisons, in terms of the number of 
recruited participants ,should be treated with a degree of caution.  
  
One of the major limitations of the current study was that longer-term follow-ups 
were not obtained, meaning no conclusions can be drawn regarding the long-term 
benefits of receiving BTB. Within the constraints of the time frame of the current 
study it was only possible to obtain one month follow-ups and the findings suggested 
that BTB treatment benefits were maintained. Ethical approval has, however, been 
obtained for longer-term follow-ups and this is in the process of being completed at 





It could be argued that the use of clinical cut-off scores for inclusion into the study 
(rather than diagnostic criteria) was a limitation of the study, as this potentially 
created a more heterogeneous sample. This could mean that the findings are limited in 
terms of the specific diagnostic categories to which the results apply. However, the 
use of clinical cut-offs as inclusion criteria has been widely used in previous research 
of BTB, with only Proudfoot et al (2003b) and Proudfoot et al (2004) using diagnostic 
criteria. It was evident in the current study that all participants scored above the 
clinical cut-offs on measures of depression, with the pre-treatment mean score in both 
groups being just within the ‘severe’ range. Similarly, the majority of participants 
scored above the clinical cut-off on the anxiety measure, with the pre-treatment mean 
in both groups being within the ‘clinical’ range, suggesting high levels of 
symptomatology in both groups with a high degree of co-morbidity. The use of 
clinical-cut offs on measures of symptomatology is reflective of what would typically 
occur in everyday practice and is in line with the goals of the primary purpose of CBT 
for older people as advocated by Laidlaw and Thompson (2008), which is symptom 
reduction.   
 
Another limitation of the study relates to the mean age of those participating in the 
study, which was 73.43 years with a range of 65 to 83 years. This means that older 
people within the ‘oldest-old’ age cohorts were not included in the study, despite no 
upper age limit being imposed. This limits the extent to which the results of the 
current study can be generalised to older age cohorts of older people. However, this is 
reflective of a number of other studies examining psychological treatments with older 




Cuijpers et al (2009), for example, in their meta-analysis, highlight that the mean age 
of participants in 20 studies examining psychological treatment for depression in 
older people was 69.28 years. Although these authors highlight some individual 
studies reported a mean age of up to 81.4 years they suggest the majority of the 
studies (15 of the 20) included in their analysis reported mean ages of less than 70 
years. This trend has been reduced to a certain extent by two recent RCTs exploring 
CBT for treating depression in older people, whereby Laidlaw et al (2009) reported 
50 per cent of their participants were over 75 years (mean = 74 years) and Serfaty et 
al (2009) reported the mean age of their participants as 74.1 years.  Within the current 
study it was evident that those who declined to participate were significantly older 
(mean = 78.32 years, range = 68 to 88 years) than those who participated. This may 
suggest that ‘older old’ age cohorts at present may be less likely to take part in a 
research study exploring BTB than younger old people. Within the current study it 
was not possible to examine reasons for non-participation in the study, which may 
have helped inform why older old people did not wish to take part. It may bee helpful 
for future research to specifically explore the attitudes of older old age cohorts toward 
BTB, which may help inform areas that could be targeted to help increase the 
likelihood of these individuals taking part in such research.  
 
A final limitation of the current study to note here was that it did not specifically 
explore participant satisfaction with using BTB, other than through indexes of this (i.e. 
the uptake rate, the discontinuation rate and the reasons for discontinuing). One 
method that could have been used was to employ a satisfaction survey. A potential 
weakness of this method is that the findings can be biased, as those dropping-out due 




be argued that more rich and detailed information can be obtained regarding 
satisfaction with BTB, as well as a number of other factors associated with the 
experience of using the program using qualitative methods (i.e. through interviewing 
participants). A study is currently being undertaken using this method with 
participants from the current study.  
 
4.6 FUTURE RESEARCH 
Throughout the previous sections a number of areas for future research have been 
mentioned, for example, introducing an initial basic computer skills training course to 
examine if this will increase the uptake rate of BTB with older people and exploring 
participants outcome at longer term follow-up, to gain a better understanding of any 
enduring benefits of the program. 
 
A particular area that would be a welcome addition to the literature on BTB would be 
to use qualitative methods to gain a more in-depth understanding of a number of 
factors associated with the use of BTB with older people. In particular, a greater 
understanding of the factors that influence the decision-making process of older 
people (in terms of whether or not they opt to receive BTB) would be helpful, in terms 
of making adaptations that may increase the acceptability of the treatment. Similarly, 
a greater understanding of the factors that influence older people deciding to 
discontinue treatment (as well as the overall experience of using BTB),  may also help 
inform how the program can be improved, which may in turn improve its efficacy. A 
follow-up qualitative study to explore each of these areas is currently being 




receive BTB, those who did opt to receive it but discontinued, and those who 
completed all eight sessions. 
 
It may also be helpful for future research to use qualitative methods to explore the 
attitudes of clinicians who work with older people towards BTB. Anecdotal evidence 
from the current study has suggested that a minority of clinicians did not approach 
any patients about their possible participation. Some limited research had been 
conducted on this and has suggested that clinicians often have much poorer attitudes 
towards CCBT than patients, although no study has explored this with reference 
specifically to older people. A greater understanding of the factors that may prevent 
clinicians from offering older people the chance to use BTB may help provide areas 
for intervention that may help to reduce any barriers to accessing this treatment.  
 
Given the promising findings of the current study, which could be regarded as a pilot 
study that has provided initial evidence regarding the effectiveness of BTB and has 
demonstrated the feasibility of its use with older people, a larger scale RCT would be 
welcome to examine in greater detail the efficacy of BTB with older people. N order 




Despite some of the limitations of the current research, by exploring BTB with a 
clinical population of older people experiencing depression and anxiety, it was the 
first study to begin to address a major gap in the literature. The findings of the study 




treatment for use with older people. The findings of the study also indicate that, in 
comparison to those who chose not to receive BTB, participants who used BTB 
obtained both statistically and clinically significant reductions in their symptoms of 
depression by the end of treatment and at one month follow-up. Although conclusions 
about these latter findings have to be treated with caution, with more research being 
required to further develop these initial findings, BTB appears to offers one potential 
treatment option to help address the fact that with an aging population there is likely 
to be an increase in demand upon under resourced services to provide psychological 
treatments for older people experiencing depression and anxiety.  
 
An important final point to make is that although there is growing evidence for the 
use of self-help treatments such as BTB, such treatments are advocated to be 
employed within matched care-service models (i.e. as first line treatments with 
patients with appropriate levels of difficulties). The importance of adequately trained 
clinicians, such as clinical psychologists, (who in addition to direct therapeutic skills 
have advanced training in research, evaluation of services and treatments, and 
supervision and training of other clinicians), are still extremely important within 
stepped/matched care service models and cannot be replaced with computer packages. 
Specialist older people clinical psychologists are small in number relative to other 
services, such as adult mental health, and nationally are well below what is stated to 
be required, based on the size of the population (Wells et al, 2010). The introduction 
of BTB to older people services can help ensure older people can be provided with an 
evidence-based psychological treatment in the context of increased demands for such 
services. However, the provision of adequate numbers of clinical psychologists 
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